Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
AADAT	"KAT2, KATII, KYAT2"	ENSG00000109576	"Aminoadipate aminotransferase"	Q8N5Z0	4	170060222-170091699	"Enzymes, Predicted intracellular proteins"		"Aminotransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 56.5"	"Cell type enhanced"	"Detected in many"	16	"Extravillous trophoblasts: 60.6;Hepatocytes: 22.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA037502	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"HPA037502: AB_10671759"	"unprognostic (1.90e-1)"	"unprognostic (1.82e-2)"	"prognostic favorable (5.59e-4)"	"unprognostic (4.21e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.97e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.28e-3)"	"unprognostic (1.17e-2)"	3.0	3.1	9.2	2.2	9.0	0.9	4.7	0.8	10.8	8.3	4.7	10.3	2.9	1.9	9.7	5.8	2.8	5.7	3.9	2.8	7.2	6.4	6.3	56.5	4.7	1.1	8.2	8.0	4.7	4.6	7.6	8.9	2.2	6.0	13.3	5.0	6.6	1.7	5.4	3.6	1.8	2.0	7.0	7.0	2.0	3.2	7.2	9.2	0.9	7.0	1.2	1.3	5.5	4.9	0.4	0.4	0.0	0.7	0.0	0.7	0.0	2.2	5.5	16.7	0.0	3.3	13.0	6.0	5.7	2.8	3.3	3.3	5.3	0.6	0.0	0.9	6.3	4.3	1.9	7.4	2.7	2.3	0.0	6.4	0.0	6.2	8.9	2.7	0.0	2.4	5.3	1.6	2.7	3.5	9.1	3.1	7.5	0.9	0.1	12.6	5.6	2.7	0.1	12.6	6.2	5.0	0.0	5.2	0.0	2.9	10.0	13.5	15.7	4.5	1.1	5.4	5.6	0.0	1.1	2.1	8.4	9.0	9.5	8.8	0.0	0.0	0.0	8.4	0.0	9.8	0.0	0.7	0.0	0.0	0.1	0.2	0.0	0.3	0.3	0.4	0.4	0.3	0.0	0.0	0.0	0.2	0.0	0.7	0.0	9.2	9.0	0.8	10.8	7.2	6.4	8.2	8.0	6.0	9.2	0.0	5.1	0.0	2.6	0.8	5.1	1.1	2.5	14.7	3.4	0.0	2.0	1.4	0.0	1.3	0.4	0.5	0.0	0.0	1.9	60.6	2.4	3.6	0.0	22.9	1.4	0.0	6.4	0.0	0.3	0.6	1.1	0.6	1.7	0.0	1.3	3.2	0.9	0.0	2.1	6.5	8.2	6.5	2.2	2.4	12.5	0.4	4.7	0.0	2.3	1.4
ABAT	GABAT	ENSG00000183044	"4-aminobutyrate aminotransferase"	P80404	16	8674565-8784575	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Neurotransmitter degradation"	"Aminotransferase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 53.3;liver: 136.5;pancreas: 54.2"	"Cell type enhanced"	"Detected in many"	19	"Hepatocytes: 234.8;Proximal tubular cells: 72.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 45.3;MCF7: 29.1;RH-30: 25.6;T-47d: 15.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041528, HPA041690"	Enhanced	Supported	Supported	Mitochondria		No	No		1500000	Mitochondria		"HPA041528: AB_10795690, HPA041690: AB_10794674"	"unprognostic (1.77e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.05e-1)"	"prognostic favorable (5.36e-5)"	"prognostic favorable (5.93e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.04e-1)"	"prognostic favorable (5.44e-8)"	"unprognostic (2.10e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.50e-2)"	2.1	12.6	26.1	2.7	39.3	1.7	3.2	19.9	43.3	2.2	5.2	10.9	0.1	17.5	2.1	5.0	3.0	2.8	2.7	6.2	20.4	30.9	53.3	136.5	2.8	2.8	24.5	26.1	5.3	54.2	4.0	22.1	2.3	14.3	9.9	4.2	2.6	2.6	2.5	1.4	2.1	8.4	2.1	14.1	2.5	3.9	6.3	11.8	1.0	12.7	0.4	3.3	6.4	1.1	2.2	1.9	8.8	5.8	1.6	2.5	1.8	0.2	0.0	12.1	6.9	1.9	0.7	0.5	1.4	0.8	0.7	0.2	4.5	0.3	1.4	0.5	0.8	0.4	3.1	0.8	2.8	0.9	0.8	0.6	2.0	0.0	45.3	3.1	0.4	3.1	2.5	1.3	1.2	0.5	0.3	0.2	3.9	0.3	1.0	0.2	29.1	0.7	0.2	1.0	8.5	0.1	3.5	25.6	0.6	0.4	7.2	1.9	5.8	0.7	0.4	0.0	2.5	15.9	1.2	0.2	0.2	2.0	0.9	0.0	1.1	0.1	0.3	0.3	2.1	1.4	1.1	3.1	4.1	2.5	3.6	1.1	0.8	1.7	1.7	1.9	2.2	1.1	1.8	8.8	1.6	5.8	0.3	1.6	1.8	26.1	39.3	19.9	35.1	20.4	30.9	24.5	26.1	14.3	11.8	0.0	5.8	12.2	3.3	1.3	16.6	8.9	15.3	2.7	7.9	1.8	3.9	1.2	19.9	1.2	8.3	1.4	10.3	0.0	5.5	1.2	2.1	9.6	1.1	234.8	4.3	33.4	15.0	5.5	9.1	6.0	3.4	5.4	1.7	0.0	4.9	48.7	6.3	6.5	4.2	72.0	6.0	0.0	2.5	1.5	0.9	0.5	1.1	7.2	6.8	4.2
ACY3	"ACY-3, HCBP1, MGC9740"	ENSG00000132744	"Aminoacylase 3"	Q96HD9	11	67642555-67650659	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 72.2;kidney: 28.9"	"Cell type enriched"	"Detected in many"	6	"Proximal tubular cells: 163.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 21.1"	"Group enriched"	"Detected in many"	6	"dendritic cells: 5.9;monocytes: 21.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 6.1;CAPAN-2: 9.5;Daudi: 34.5;OE19: 9.6;RPMI-8226: 6.0"	"Low region specificity"	"Detected in all"							"HPA039219, HPA048187"	Enhanced					NA	NA					"HPA039219: AB_10671872, HPA048187: AB_2680306"	"unprognostic (8.37e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.04e-1)"	"prognostic favorable (4.80e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.37e-4)"	"unprognostic (2.44e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.63e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.24e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.48e-3)"	0.1	0.1	3.4	1.8	5.5	0.6	0.5	0.8	7.8	5.5	13.0	15.3	0.2	38.2	0.3	2.1	0.7	0.4	6.1	0.1	3.1	2.9	28.9	18.3	0.2	3.1	4.6	5.1	0.1	11.2	0.0	0.3	0.1	7.1	0.4	2.2	0.3	1.2	0.2	0.1	0.1	72.2	0.1	5.2	0.9	5.9	0.1	2.8	0.7	0.2	0.0	4.2	0.2	0.2	1.1	5.9	0.0	21.1	2.3	0.9	1.2	0.1	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.1	9.5	34.5	0.4	0.0	0.9	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	3.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	1.2	1.5	0.0	9.6	0.0	1.1	0.0	6.0	0.0	0.0	0.0	0.1	0.2	0.8	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	3.8	0.3	0.0	0.5	0.0	0.1	4.9	0.5	1.0	0.2	0.1	2.6	1.1	0.9	0.6	0.0	2.3	21.1	5.9	0.0	1.2	3.4	5.5	0.8	7.8	3.1	2.9	4.6	5.1	7.1	2.8	0.0	1.7	6.3	0.1	0.0	0.0	0.4	10.2	0.0	1.2	21.0	0.0	0.2	26.6	3.5	0.0	0.0	11.8	0.0	9.0	0.2	0.0	0.6	0.0	17.9	1.7	0.0	1.2	0.0	0.3	0.0	0.0	0.9	5.0	0.0	25.1	0.0	6.8	5.9	0.0	163.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.9	6.6	0.8
ALDH4A1	"ALDH4, P5CDh"	ENSG00000159423	"Aldehyde dehydrogenase 4 family member A1"	P30038	1	18871430-18902781	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Proline metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 73.7;liver: 92.6"	"Cell type enhanced"	"Detected in many"	16	"Hepatocytes: 313.9;Proximal tubular cells: 167.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 72.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Hep G2: 34.6;SK-BR-3: 35.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004645, HPA006401, HPA072759"	Enhanced		Supported	Mitochondria		NA	NA		40000	Mitochondria		"CAB004645: AB_425775, HPA006401: AB_1844731, HPA072759: "	"unprognostic (1.17e-1)"	"prognostic favorable (5.06e-4)"	"unprognostic (1.38e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.15e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.27e-3)"	"unprognostic (9.41e-3)"	"unprognostic (3.83e-1)"	"unprognostic (2.69e-3)"	"unprognostic (9.34e-2)"	22.9	4.1	14.4	2.0	18.0	4.6	6.6	3.1	16.8	3.8	2.4	8.6	18.9	1.3	2.5	5.2	11.4	2.7	3.0	12.6	8.6	7.1	73.7	92.6	2.4	1.7	15.9	11.2	2.9	2.2	9.4	2.4	8.3	8.5	12.1	1.6	9.7	2.4	12.1	25.6	8.0	1.3	3.3	2.7	2.1	3.4	1.4	6.6	2.8	3.0	8.9	2.9	8.3	3.6	1.5	7.2	2.6	5.6	0.3	1.4	2.2	5.1	8.0	4.1	12.1	17.4	2.6	10.0	4.9	3.0	5.1	4.1	5.8	3.8	3.4	6.6	6.4	2.4	13.8	6.9	14.7	1.9	1.9	6.1	1.9	1.9	34.6	5.5	1.7	6.2	6.7	8.2	2.8	2.8	3.8	5.7	5.8	7.7	2.5	3.4	13.2	1.7	8.3	2.0	10.6	4.1	10.7	3.4	4.0	5.3	13.0	8.1	3.1	8.7	35.8	6.4	6.5	16.3	2.6	4.7	4.4	5.8	5.3	1.7	2.8	6.6	1.0	1.6	13.5	5.8	0.0	4.1	2.6	1.1	5.6	0.9	1.5	0.7	1.4	7.2	1.1	0.3	0.9	0.6	0.3	3.1	2.4	1.0	2.2	14.4	18.0	3.1	16.8	8.6	7.1	15.9	11.2	8.5	6.6	0.0	3.2	7.2	14.0	6.6	3.1	18.5	38.2	1.4	0.0	43.6	9.8	61.1	39.7	5.6	0.4	2.7	0.4	0.0	0.8	7.2	2.3	9.5	4.6	313.9	11.9	19.1	2.4	16.5	14.0	0.4	1.1	1.4	3.3	17.2	2.9	10.8	2.9	1.5	2.5	167.5	4.2	6.5	4.3	2.1	3.6	4.6	72.4	2.2	3.3	9.7
ALDH5A1	"SSADH, SSDH"	ENSG00000112294	"Aldehyde dehydrogenase 5 family member A1"	P51649	6	24494852-24537207	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 62.6"	"Cell type enhanced"	"Detected in many"	10	"Hepatocytes: 85.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 41.1;U-698: 51.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029715, HPA029716"	Enhanced		Supported	Mitochondria		NA	NA		44000	Mitochondria		"HPA029715: AB_10599994, HPA029716: AB_10601876"	"unprognostic (7.43e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.27e-1)"	"prognostic favorable (7.61e-6)"	"unprognostic (2.38e-2)"	"unprognostic (2.17e-2)"	"prognostic favorable (6.20e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (3.68e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.08e-2)"	5.8	4.8	23.7	8.3	27.4	3.1	4.1	13.5	21.5	4.1	6.0	9.5	1.2	7.7	3.9	3.1	5.6	13.5	4.4	9.8	17.3	21.0	18.4	62.6	5.0	8.9	16.0	14.7	5.8	6.6	11.4	4.5	2.2	13.0	6.2	5.7	4.1	3.9	4.3	31.1	6.9	5.4	2.8	10.9	4.8	5.2	3.7	8.8	21.4	12.1	4.9	8.8	6.3	5.5	3.9	3.8	0.4	0.2	1.6	6.8	1.2	3.2	3.0	2.1	3.2	0.0	0.0	3.5	0.3	0.6	0.8	0.5	11.7	0.8	41.1	6.2	0.3	0.7	0.0	3.4	0.4	0.5	4.2	5.7	6.4	1.9	13.4	0.5	9.9	0.8	0.3	1.6	0.1	0.0	2.3	0.0	11.3	3.2	0.0	0.6	7.6	12.0	5.9	0.8	5.8	1.5	13.9	0.6	0.4	2.5	6.6	3.7	3.3	3.8	0.4	4.0	0.9	5.9	5.4	0.0	0.4	2.1	0.1	2.1	5.8	8.6	51.4	0.0	3.1	0.4	0.4	0.1	0.2	1.7	0.0	3.3	3.7	2.4	2.8	0.2	3.9	6.8	5.7	0.4	1.6	0.2	3.8	1.6	1.2	23.7	27.4	13.5	21.5	17.3	21.0	16.0	14.7	13.0	8.8	14.9	22.3	8.8	4.6	1.4	10.6	29.9	5.1	13.4	9.1	7.0	15.7	5.0	1.7	1.8	0.5	3.1	8.4	23.3	0.8	4.3	2.1	5.1	6.9	85.5	3.2	15.9	8.1	6.7	3.8	0.0	3.1	2.0	1.7	0.0	10.5	10.4	1.3	3.5	4.2	24.0	6.5	0.0	1.6	1.4	6.1	2.6	1.6	5.4	16.7	11.5
ASL		ENSG00000126522	"Argininosuccinate lyase"	P04424	7	66075798-66093558	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 99.5"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 226.8;Hepatocytes: 477.5;Paneth cells: 217.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB003696, HPA016646"	Enhanced		Approved	Cytosol		NA	NA		10000000	Cytosol		"CAB003696: AB_425316, HPA016646: AB_1845096"	"unprognostic (2.95e-2)"	"prognostic unfavorable (4.05e-6)"	"unprognostic (4.83e-1)"	"unprognostic (4.18e-3)"	"unprognostic (3.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.49e-2)"	"unprognostic (7.25e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.19e-1)"	"unprognostic (8.40e-3)"	5.6	4.8	4.0	8.0	4.3	7.3	5.9	7.2	7.4	5.5	17.2	3.7	7.8	20.8	5.0	7.1	7.7	4.9	19.5	4.3	3.7	4.3	16.0	99.5	8.1	4.5	4.4	6.2	5.9	10.4	3.3	5.8	3.3	7.2	5.4	12.4	5.8	7.1	5.7	2.4	4.1	16.6	3.4	3.2	8.6	12.6	2.1	3.5	1.2	7.1	7.9	5.9	5.2	5.9	8.6	19.3	20.7	18.4	30.4	9.2	10.7	18.2	7.5	4.1	14.8	9.5	7.3	9.0	12.8	11.2	18.3	16.7	16.9	22.6	5.6	20.5	16.8	13.3	5.0	2.6	21.7	5.3	4.6	3.4	7.4	7.3	26.1	17.7	8.4	21.7	13.7	7.9	12.8	20.5	4.6	18.0	4.0	13.1	10.7	10.1	13.0	1.7	11.6	6.2	22.8	9.7	4.5	4.3	19.3	13.3	11.0	7.1	9.7	11.7	40.8	4.4	4.4	17.8	7.6	20.4	23.2	12.0	9.2	16.5	11.7	6.1	7.3	21.9	16.0	18.7	12.1	18.1	20.7	7.7	18.4	6.5	8.6	5.2	6.1	19.3	5.6	3.7	4.0	4.0	30.4	13.8	1.2	9.2	10.7	4.0	4.3	7.2	7.4	3.7	4.3	4.4	6.2	7.2	3.5	17.9	52.0	20.8	16.7	4.8	12.5	7.1	132.5	38.8	15.9	29.6	21.6	19.3	44.7	51.9	3.5	25.6	226.8	0.0	192.3	35.3	14.5	13.1	44.9	477.5	40.4	14.3	51.9	35.6	39.6	4.9	8.6	16.1	8.5	61.3	87.3	6.5	99.6	217.5	7.8	174.9	12.2	12.9	13.9	3.0	5.8	3.8	18.7	27.5	126.5	20.6
ASNS		ENSG00000070669	"Asparagine synthetase (glutamine-hydrolyzing)"	P08243	7	97852118-97872542	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Asparagine biosynthesis"	Ligase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 68.0"	"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 197.3;Erythroid cells: 93.5;Late spermatids: 147.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"B-cells: 8.6;T-cells: 13.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004924, HPA029318, HPA064737"	Approved		Enhanced	Cytosol		No	No			Cytosol		"HPA004924: AB_2667295, HPA029318: AB_10602389, HPA064737: AB_2685341"	"unprognostic (3.93e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.70e-2)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (8.79e-5)"	"prognostic unfavorable (9.42e-6)"	"unprognostic (2.28e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.89e-1)"	"unprognostic (8.10e-3)"	"unprognostic (2.53e-3)"	"prognostic unfavorable (6.21e-7)"	"unprognostic (5.33e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.33e-1)"	6.5	7.5	15.9	10.9	21.4	7.6	9.9	31.7	32.3	5.7	10.1	9.4	5.6	6.5	10.0	19.9	10.2	6.9	6.8	9.2	24.5	20.4	6.5	5.9	9.6	16.0	16.3	13.4	19.2	68.0	16.7	16.7	3.2	35.9	9.2	12.7	4.4	49.9	9.3	3.5	13.6	7.8	11.3	20.6	11.0	20.8	16.9	9.2	3.6	16.7	8.2	15.0	9.6	6.6	8.6	1.4	1.5	1.2	2.2	13.2	3.2	19.0	7.3	7.4	60.1	5.9	8.3	18.1	14.1	9.0	6.7	20.2	9.4	7.6	15.0	7.1	28.7	14.0	8.7	19.1	22.3	16.1	18.7	14.1	4.8	3.7	7.0	54.3	30.6	13.5	16.3	75.0	8.8	54.5	3.6	5.5	14.1	26.8	53.3	10.6	40.3	0.9	8.1	10.1	45.6	20.0	2.3	1.4	39.3	4.3	3.7	32.3	24.3	3.6	19.6	76.0	9.9	8.3	21.5	1.4	3.3	22.1	8.8	6.6	63.1	31.5	57.1	41.8	13.9	32.1	1.5	0.3	0.5	3.8	1.2	4.9	8.6	7.4	3.4	1.4	6.2	10.2	5.5	1.5	2.2	0.8	0.1	13.2	3.2	15.9	21.4	31.7	32.3	24.5	20.4	16.3	13.4	35.9	9.2	8.9	4.5	3.7	18.8	11.0	20.1	5.9	12.7	1.4	3.4	8.7	23.6	2.0	6.6	34.4	197.3	3.1	1.7	93.5	52.9	7.7	6.6	17.6	8.1	1.6	1.0	23.8	23.4	2.5	0.6	147.0	8.9	1.8	8.5	11.8	12.9	8.5	38.4	11.9	8.9	3.1	25.4	6.5	12.3	2.3	7.0	9.5	4.7	13.3	7.9	15.2
ASPA	"ACY2, ASP"	ENSG00000108381	Aspartoacylase	P45381	17	3472374-3503419	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 51.3;kidney: 33.2"	"Group enriched"	"Detected in many"	4	"Collecting duct cells: 24.4;Leydig cells: 46.1;Melanocytes: 43.9;Peritubular cells: 45.3;Proximal tubular cells: 65.3"	"Cancer enhanced"	"Detected in some"		"renal cancer: 7.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 8.3;ASC TERT1: 6.5;CACO-2: 5.5;HSkMC: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022142, HPA022145"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA022142: AB_1845102, HPA022145: AB_1845103"	"unprognostic (4.42e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.79e-3)"	"unprognostic (4.36e-2)"	"unprognostic (5.01e-1)"	"unprognostic (1.08e-3)"	"unprognostic (3.57e-1)"	"unprognostic (4.17e-1)"	"unprognostic (3.43e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.07e-4)"	"unprognostic (2.77e-1)"	"unprognostic (4.68e-1)"	"unprognostic (1.49e-1)"	10.9	4.1	14.5	1.8	37.6	1.7	3.3	3.0	19.4	6.2	3.6	35.2	3.1	9.7	4.1	5.5	4.5	5.0	3.3	2.2	21.9	11.0	33.2	12.6	3.2	1.3	50.2	11.3	2.9	1.0	0.9	0.9	3.1	18.9	4.0	4.6	2.6	1.9	4.8	9.3	4.6	13.3	2.9	22.4	4.6	3.9	5.6	51.3	0.0	1.8	1.1	0.8	4.5	3.5	1.7	1.2	3.6	0.7	1.6	1.3	0.2	0.4	0.2	0.9	0.7	8.3	6.5	0.5	0.4	0.3	0.3	0.3	5.5	0.3	1.1	0.3	1.0	0.5	0.5	0.5	0.3	0.4	2.9	0.3	0.5	0.9	0.4	0.9	0.7	0.8	11.7	0.6	0.7	0.2	0.4	0.1	0.7	0.6	2.0	0.4	0.4	0.4	1.0	0.8	0.4	0.5	0.4	0.5	0.9	0.4	1.7	0.7	0.5	1.6	0.6	1.3	0.8	0.6	0.3	0.6	1.0	0.7	0.7	0.4	1.2	0.6	0.7	0.4	0.6	0.8	3.4	0.7	0.8	1.2	0.6	1.0	1.1	1.0	0.9	0.5	1.7	1.2	1.3	3.6	1.6	0.7	1.2	0.5	0.2	14.5	37.6	3.0	19.4	21.9	11.0	50.2	11.3	18.9	51.3	8.9	1.0	0.0	1.2	4.6	0.4	0.8	5.1	0.0	1.2	24.4	0.0	0.0	6.6	0.0	2.8	0.5	1.0	0.0	0.2	0.1	7.4	0.3	0.0	10.2	0.2	7.9	2.4	4.9	1.5	0.5	46.1	0.8	43.9	0.0	0.1	3.4	0.0	0.0	45.3	65.3	0.5	0.0	4.2	4.8	0.6	1.5	0.1	0.0	1.2	1.7
ASPG	C14orf76	ENSG00000166183	Asparaginase	Q86U10	14	104085679-104115581	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"heart muscle: 29.7;liver: 88.7"	"Cell type enhanced"	"Detected in many"	20	"Cardiomyocytes: 19.5;Hepatocytes: 83.1;Proximal tubular cells: 39.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.0"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.6;HDLM-2: 3.0;HeLa: 2.5;HMC-1: 3.2;RPTEC TERT1: 1.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA069761	Enhanced					NA	NA					"HPA069761: AB_2686191"	"unprognostic (1.45e-2)"	"unprognostic (7.43e-3)"	"unprognostic (2.38e-3)"	"unprognostic (1.30e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.75e-2)"	"unprognostic (7.98e-2)"	"unprognostic (3.85e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.32e-2)"	0.7	0.5	0.4	0.4	0.5	0.0	2.1	0.4	0.5	1.5	2.3	0.5	0.4	0.5	1.6	1.0	10.2	2.0	0.8	29.7	0.4	0.0	9.8	88.7	1.3	0.9	0.4	0.4	4.9	0.4	0.7	0.4	0.8	0.7	0.4	0.8	1.2	0.8	0.4	0.4	5.2	0.8	1.1	0.4	0.4	1.6	0.9	0.4	0.4	1.3	0.6	1.7	0.5	2.8	0.2	0.0	1.0	0.1	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.2	1.8	0.8	2.6	0.0	0.0	0.2	0.0	0.0	0.0	3.0	0.0	0.0	2.5	0.0	0.0	0.0	3.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.0	0.1	0.7	1.0	0.0	0.7	0.6	1.9	1.9	1.5	1.2	0.0	0.1	0.8	0.2	1.2	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.4	0.5	0.4	0.5	0.4	0.0	0.4	0.4	0.7	0.4	6.0	1.7	0.0	0.1	1.5	1.0	19.5	2.5	2.7	0.0	0.0	0.0	0.1	3.3	0.0	0.4	0.3	8.4	0.0	0.2	0.1	0.6	0.2	0.0	83.1	0.2	4.8	1.7	3.7	0.6	0.0	0.0	0.0	0.0	0.0	10.8	0.2	0.3	5.9	1.1	39.3	0.2	0.0	0.0	0.4	0.7	8.0	0.5	0.0	3.0	2.5
ASRGL1	"ALP, ALP1, FLJ22316"	ENSG00000162174	"Asparaginase like 1"	Q7L266	11	62337448-62393412	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 52.4;cervix, uterine: 68.7;testis: 57.6"	"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 275.4;Late spermatids: 421.8;Spermatocytes: 320.2"	"Cancer enhanced"	"Detected in all"		"endometrial cancer: 53.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 51.4;eosinophil: 52.4"	"Group enriched"	"Detected in many"	4	"granulocytes: 52.4;monocytes: 14.2"	"Cell line enhanced"	"Detected in many"		"EFO-21: 30.5;HAP1: 29.4;RPTEC TERT1: 26.0;SCLC-21H: 40.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029725, HPA055572, CAB070192"	Enhanced		Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge"		NA	NA			Microtubules	"Nucleoplasm, Cytokinetic bridge"	"CAB070192: AB_2665720, HPA029725: AB_10602328, HPA055572: AB_2682854"	"unprognostic (1.14e-1)"	"unprognostic (8.38e-3)"	"prognostic favorable (6.14e-4)"	"prognostic favorable (1.56e-5)"	"unprognostic (5.35e-2)"	"unprognostic (8.19e-2)"	"prognostic unfavorable (9.46e-4)"	"unprognostic (8.67e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.71e-1)"	"unprognostic (4.44e-1)"	"prognostic favorable (4.32e-7)"	"unprognostic (2.28e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.43e-3)"	"unprognostic (1.40e-1)"	3.6	2.6	27.8	3.8	37.0	7.1	4.6	12.3	22.3	68.7	7.9	9.9	2.0	4.1	15.3	7.9	1.4	36.8	9.5	1.7	19.5	19.0	23.8	2.4	6.6	3.3	30.8	11.8	1.6	5.1	1.5	5.7	2.3	16.4	8.6	9.9	4.9	6.4	4.8	2.3	1.2	3.1	3.0	9.6	2.4	5.6	57.6	11.3	2.8	3.7	0.0	3.0	2.9	1.0	0.5	8.2	52.4	14.2	2.5	0.7	4.9	0.8	6.7	7.4	9.6	0.0	0.0	5.8	0.8	0.3	1.3	1.2	11.0	3.0	0.7	30.5	0.1	3.3	0.6	29.4	0.3	1.5	1.1	12.1	0.4	9.1	8.0	0.2	8.1	11.0	0.3	0.1	0.6	0.1	0.4	13.8	16.7	8.2	7.6	0.3	12.8	21.8	5.4	10.1	4.6	5.3	8.9	4.4	4.1	26.0	2.1	40.1	5.7	5.7	9.9	4.9	8.0	5.3	4.1	0.7	0.1	5.6	0.4	3.3	11.7	11.1	1.0	0.3	4.2	3.4	51.4	14.2	52.4	0.6	10.3	0.4	0.5	0.2	0.7	8.2	0.4	0.5	0.7	3.3	2.5	7.2	1.4	0.1	4.9	27.8	37.0	12.3	22.3	19.5	19.0	30.8	11.8	16.4	11.3	6.0	26.7	10.4	1.9	3.1	21.7	1.6	53.5	1.4	3.4	21.0	31.4	1.4	112.7	25.5	275.4	23.3	4.1	0.0	19.3	1.8	3.8	54.4	76.5	2.6	22.5	15.9	45.3	31.9	9.1	421.8	8.1	27.7	1.7	0.0	35.8	78.6	8.8	5.8	6.7	99.6	37.4	12.9	2.3	320.2	48.6	1.1	0.7	6.9	26.0	5.3
ASS1	"ASS, CTLN1"	ENSG00000130707	"Argininosuccinate synthase 1"	P00966	9	130444929-130501274	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle"	Ligase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 121.5;liver: 309.9"	"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 457.5;Hepatocytes: 809.9;Proximal tubular cells: 889.6;Urothelial cells: 385.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	15	"plasmacytoid DC: 4.6"	"Lineage enriched"	"Detected in single"	46	"dendritic cells: 4.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 87.4;HaCaT: 82.8;hTCEpi: 80.5;RPMI-8226: 134.1;THP-1: 100.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA020896, HPA020934"	Enhanced		Approved	Nucleoplasm,Cytosol		No	No		4500000	Cytosol	Nucleoplasm	"HPA020896: AB_1845117, HPA020934: AB_1845118"	"unprognostic (3.73e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (8.14e-9)"	"unprognostic (3.06e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.71e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.02e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.14e-1)"	"unprognostic (4.72e-3)"	20.6	15.4	4.6	7.1	4.1	0.0	15.7	2.3	5.4	8.3	18.5	3.5	33.9	11.9	12.0	12.6	9.4	16.6	14.0	11.4	3.8	5.7	121.5	309.9	8.0	2.2	3.2	4.3	11.4	7.9	0.5	4.6	8.7	4.5	12.1	16.8	10.7	26.3	40.6	7.4	12.5	26.8	5.9	3.4	2.7	5.2	8.7	2.2	0.8	17.5	7.0	4.5	17.7	8.6	0.0	4.6	0.0	0.0	0.0	0.0	0.0	11.7	1.1	1.3	2.2	8.9	22.7	4.3	14.0	87.4	2.8	8.5	5.0	3.3	0.0	9.5	28.9	0.8	82.8	5.8	0.5	1.9	2.0	2.6	0.0	1.8	12.8	31.0	1.7	0.1	15.0	80.5	4.5	8.1	0.0	0.1	37.6	0.4	52.2	2.8	58.1	0.6	24.5	1.8	60.2	2.6	0.1	1.5	134.1	7.6	5.8	33.8	0.5	50.0	52.7	3.9	5.4	36.2	100.4	0.0	1.1	7.0	0.2	1.2	8.7	8.3	2.9	22.0	13.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	4.6	4.1	2.3	5.4	3.8	5.7	3.2	4.3	4.5	2.2	23.8	25.8	33.7	45.3	62.6	0.0	5.0	94.3	20.1	50.0	45.4	0.0	159.6	112.7	79.7	0.8	23.2	457.5	0.0	98.3	5.0	15.7	85.0	5.7	809.9	12.7	0.0	11.5	35.0	18.0	2.7	28.7	2.6	3.3	2.8	129.1	4.8	73.5	143.8	117.4	889.6	0.3	0.0	10.8	1.1	2.0	15.3	120.5	12.5	77.1	385.2
CPS1		ENSG00000021826	"Carbamoyl-phosphate synthase 1"	P31327	2	210477682-210679107	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Urea cycle"	"Allosteric enzyme, Ligase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"liver: 298.3"	"Cell type enriched"	"Detected in many"	72	"Hepatocytes: 1670.2"	"Cancer enriched"	"Detected in many"	8	"liver cancer: 136.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 90.5;SK-BR-3: 27.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB003781, HPA021400"	Enhanced		Supported	"Nucleoli,Nucleoli rim"		NA	NA		2100000	"Nucleoli, Nucleoli rim"		"CAB003781: , HPA021400: AB_1847197"	"unprognostic (1.67e-2)"	"unprognostic (3.72e-2)"	"unprognostic (4.02e-2)"	"unprognostic (7.21e-7)"	"unprognostic (3.81e-2)"	"unprognostic (2.52e-1)"	"prognostic favorable (6.93e-5)"	"unprognostic (1.23e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.94e-3)"	"unprognostic (2.38e-4)"	"unprognostic (5.90e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.14e-2)"	"unprognostic (3.74e-2)"	0.4	0.1	0.5	0.3	1.6	0.0	0.8	0.3	0.7	0.4	0.2	0.7	0.3	31.5	0.3	0.7	0.5	0.2	0.4	0.3	0.5	0.4	0.6	298.3	0.2	0.3	1.5	0.8	0.7	0.2	0.0	0.4	1.1	1.4	0.3	0.0	0.6	0.2	0.2	0.3	0.3	17.2	0.4	2.3	0.3	0.2	1.3	0.5	0.0	0.4	0.4	0.1	0.2	0.4	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.3	2.4	6.3	4.3	4.2	7.4	6.7	2.3	2.7	2.7	4.2	0.6	0.0	1.0	0.1	2.5	3.8	1.1	0.2	3.8	6.8	0.0	1.9	4.0	90.5	5.6	1.4	2.1	0.0	3.8	2.8	5.3	5.4	6.9	0.3	1.7	4.0	0.3	4.4	1.1	0.1	0.2	2.4	0.0	0.6	0.2	5.8	0.5	5.7	0.0	0.1	0.4	15.8	27.3	3.0	8.5	0.0	0.7	3.0	7.0	2.1	2.1	4.9	0.0	0.3	0.0	4.6	4.4	4.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.3	0.7	0.5	0.4	1.5	0.8	1.4	0.5	11.9	9.6	20.7	0.5	1.9	1.1	0.7	15.3	1.4	6.8	1.8	7.9	0.3	0.0	0.1	23.2	1.4	0.3	23.3	0.2	0.4	2.5	1.2	3.5	1670.2	0.2	0.0	0.0	16.5	22.7	3.6	2.3	1.8	1.7	0.0	0.1	1.4	0.0	0.0	1.1	0.7	2.2	0.0	2.5	0.3	1.1	1.6	17.4	5.0	0.1	0.4
CRCP	"CGRP-RCP, RCP, RCP9"	ENSG00000241258	"CGRP receptor component"	O75575	7	66114604-66154568	"Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007216	Approved		Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA007216: AB_1856160"	"unprognostic (2.36e-2)"	"unprognostic (4.43e-1)"	"unprognostic (2.32e-3)"	"unprognostic (1.42e-3)"	"unprognostic (3.38e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.67e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.77e-3)"	"unprognostic (2.59e-3)"	"unprognostic (8.49e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.39e-3)"	"unprognostic (3.87e-2)"	"unprognostic (4.81e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.06e-1)"	19.0	19.8	18.5	13.1	21.5	32.5	18.7	26.1	23.3	18.2	18.8	17.0	19.6	16.5	20.9	16.1	21.4	19.4	15.8	18.1	15.4	18.9	17.7	22.3	17.0	15.5	16.0	19.5	19.8	33.9	23.7	22.3	14.2	16.7	18.9	21.3	17.6	31.6	17.9	19.5	20.5	14.6	21.8	18.8	16.5	17.8	19.1	15.6	15.0	21.3	13.3	17.1	22.2	20.0	14.5	11.3	20.2	14.6	9.2	17.7	10.5	17.7	11.7	7.9	10.8	11.8	15.0	8.0	12.0	14.0	19.2	14.9	17.6	14.7	15.6	15.2	11.4	15.8	13.1	11.0	15.2	20.0	10.7	10.8	8.9	7.6	7.5	7.7	18.8	13.5	11.8	13.7	16.5	31.5	12.0	10.3	9.3	20.0	12.2	12.8	13.5	14.0	13.3	16.2	24.2	14.1	14.9	12.8	15.6	11.1	16.4	19.6	26.0	14.2	39.5	12.0	9.9	31.8	9.1	11.5	26.7	14.2	14.9	22.6	15.1	27.8	22.1	15.3	14.7	21.4	18.9	11.7	18.5	17.7	10.1	17.3	14.2	15.3	14.4	8.5	14.5	14.7	17.1	20.2	9.2	14.6	11.3	14.7	10.5	18.5	21.5	26.1	23.3	15.4	18.9	16.0	19.5	16.7	15.6	26.8	23.8	16.4	18.7	11.8	29.5	21.6	10.2	50.9	29.6	15.7	21.6	10.9	29.9	17.3	3.3	12.4	9.8	0.0	21.5	10.0	11.6	21.9	32.4	22.5	10.8	28.6	15.4	10.4	9.9	3.0	17.3	13.5	15.1	20.8	13.3	19.3	22.0	12.7	20.8	13.7	22.8	6.5	11.3	21.6	16.8	12.9	9.6	25.5	12.0	27.4
DDO		ENSG00000203797	"D-aspartate oxidase"	Q99489	6	110391771-110415562	"Enzymes, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 14.1;Muller glia cells: 9.1;Proximal tubular cells: 9.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 4.9;myeloid DC: 7.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"GAMG: 10.9;RPMI-8226: 14.2;U-937: 15.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037525, HPA037526"	Enhanced		Enhanced	Cytosol		NA	NA			Cytosol		"HPA037525: AB_2675523, HPA037526: AB_10672352"	"unprognostic (1.37e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.91e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.43e-1)"	"prognostic favorable (8.69e-5)"	"unprognostic (3.51e-4)"	"unprognostic (3.36e-3)"	"unprognostic (1.27e-3)"	"unprognostic (9.06e-2)"	3.7	11.0	5.2	1.1	12.1	1.6	3.3	1.9	5.5	2.7	3.6	10.8	4.9	8.6	2.7	5.4	1.2	6.1	3.9	21.0	6.9	3.4	12.3	12.8	3.9	1.3	8.0	6.1	1.2	5.5	18.6	1.9	2.1	8.0	2.9	3.9	2.3	4.9	3.2	11.3	0.8	7.9	5.6	7.7	2.6	1.9	0.4	8.2	0.0	3.3	5.7	0.5	3.6	1.6	0.0	7.3	0.1	4.9	1.7	0.0	1.5	0.1	0.0	0.0	0.1	0.0	0.2	1.0	0.1	5.0	1.2	0.8	0.0	0.0	0.0	0.7	0.7	10.9	0.0	0.0	0.0	2.2	4.5	0.0	4.6	0.0	3.9	1.6	0.0	0.0	0.1	0.0	2.5	0.1	2.2	0.0	0.0	0.0	1.8	4.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	2.8	14.2	0.0	4.5	0.1	0.1	0.0	0.4	0.6	0.0	0.7	1.0	0.8	1.0	0.1	0.0	2.3	0.1	0.3	0.0	1.9	15.8	0.0	0.1	4.6	0.0	0.0	4.9	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.1	1.7	1.6	0.0	0.0	1.5	5.2	12.1	1.9	5.5	6.9	3.4	8.0	6.1	8.0	8.2	0.0	0.0	0.0	0.8	0.0	0.0	14.1	0.0	1.4	0.0	0.0	2.0	0.1	3.3	2.8	0.0	0.3	2.7	0.0	1.9	0.1	0.3	0.3	0.0	4.4	1.8	0.0	4.1	2.5	4.0	0.0	0.3	1.1	0.0	1.0	5.9	9.1	1.2	6.0	0.0	9.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	3.5	0.3
FH	fumarase	ENSG00000091483	"Fumarate hydratase"	P07954	1	241497603-241519761	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Tricarboxylic acid cycle"	Lyase	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 93.4"	"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 161.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017785, HPA025770, HPA025948, HPA027341"	Enhanced	Supported	Enhanced	Mitochondria		NA	NA		2800000	Mitochondria		"CAB017785: , HPA025770: AB_10599603, HPA025948: AB_10602177, HPA027341: AB_10601222"	"unprognostic (1.03e-2)"	"unprognostic (3.82e-2)"	"unprognostic (9.46e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.09e-1)"	"prognostic favorable (2.76e-7)"	"unprognostic (1.05e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.24e-2)"	14.3	28.1	15.7	10.4	20.2	9.3	13.3	15.7	24.4	10.5	22.7	9.9	16.7	23.2	13.7	10.7	17.7	10.3	9.5	59.0	22.9	13.9	35.0	93.4	9.9	13.3	15.2	19.4	9.4	13.9	25.2	11.4	14.3	18.4	12.3	24.4	10.2	18.4	20.6	65.1	13.4	21.4	14.7	14.4	11.1	17.5	14.0	11.7	13.8	12.3	45.2	13.4	13.4	11.2	16.0	26.4	4.5	18.8	10.4	13.9	8.9	29.3	24.6	23.3	21.0	22.9	27.1	37.0	36.4	28.5	41.1	25.8	35.1	18.3	18.6	24.1	27.8	18.0	41.8	35.6	27.0	35.8	21.3	11.5	17.5	26.0	30.0	20.6	40.8	15.9	19.6	16.9	23.0	26.0	14.4	25.2	41.2	53.1	24.1	29.9	14.6	35.1	27.3	24.8	42.8	52.8	29.1	25.5	83.6	39.6	24.9	30.0	26.0	30.6	36.3	23.2	16.8	27.7	27.7	24.8	18.5	23.8	32.6	60.5	21.6	23.1	22.6	20.6	46.9	26.5	4.5	12.8	2.7	9.7	18.8	12.6	16.0	11.4	9.0	26.4	14.1	13.9	12.7	0.7	10.4	15.7	13.2	13.2	8.9	15.7	20.2	15.7	24.4	22.9	13.9	15.2	19.4	18.4	11.7	35.7	27.5	27.0	18.6	17.7	23.0	151.3	33.1	30.8	22.7	22.7	13.7	91.1	66.3	49.6	161.2	17.9	46.4	23.3	39.2	43.6	21.6	16.1	18.5	73.1	45.3	33.4	17.2	11.6	12.6	20.1	22.2	26.8	23.6	29.7	35.6	28.0	29.4	35.1	25.1	58.8	32.6	38.8	21.7	82.8	44.5	16.3	138.9	12.9	60.7	16.3
GAD1	GAD	ENSG00000128683	"Glutamate decarboxylase 1"	Q99259	2	170813213-170861151	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Neurotransmitter biosynthesis"	"Decarboxylase, Lyase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 53.9"	"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 9.8;Distal tubular cells: 6.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 10.8;HEL: 34.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"olfactory region: 888.9"	"CAB004415, HPA048871, HPA058412, CAB078176"	Enhanced	Supported	Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane, Cytosol"		"CAB004415: AB_627650, CAB078176: AB_2665792, HPA048871: , HPA058412: AB_2683710"	"unprognostic (1.28e-1)"	"prognostic favorable (7.31e-4)"	"unprognostic (1.87e-2)"	"prognostic favorable (8.61e-4)"	"unprognostic (1.12e-1)"	"unprognostic (3.05e-1)"	"unprognostic (4.97e-7)"	"unprognostic (1.51e-1)"	"unprognostic (7.72e-2)"	"unprognostic (4.27e-4)"	"unprognostic (6.75e-2)"	"unprognostic (9.18e-3)"	"unprognostic (6.90e-5)"	"unprognostic (2.93e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.08e-3)"	1.2	2.0	14.5	0.9	28.1	3.7	1.0	10.6	53.9	1.8	1.0	3.1	0.0	1.0	2.6	5.5	1.2	1.1	1.0	1.0	10.8	24.4	6.0	1.0	1.1	1.1	8.6	17.5	1.1	1.1	9.5	2.8	1.4	6.0	1.8	1.0	1.3	1.0	1.3	0.9	1.0	1.1	1.0	2.6	1.0	1.0	4.0	3.4	0.0	1.1	0.0	1.2	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.4	0.0	3.8	0.0	0.0	0.0	0.2	0.0	1.4	0.9	2.5	3.6	0.0	0.5	0.2	1.7	10.8	1.2	0.3	0.8	1.4	7.4	34.9	3.0	0.1	0.0	0.1	0.6	0.0	3.1	0.0	1.2	0.3	0.0	0.3	9.0	0.1	0.4	0.8	0.0	0.0	4.3	5.2	3.8	0.5	2.6	0.2	4.7	5.0	3.7	1.2	6.6	0.0	1.8	0.3	0.1	0.0	0.0	6.5	0.9	1.3	3.8	0.0	0.0	0.0	6.3	1.7	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	28.1	10.6	36.7	10.8	24.4	8.6	17.5	6.0	3.4	0.0	0.0	0.0	1.4	0.2	3.8	1.1	0.0	0.0	0.0	0.0	9.8	0.0	6.6	4.2	4.3	0.3	0.0	0.0	4.7	0.1	0.2	0.8	0.0	0.0	3.0	4.8	2.9	0.0	0.3	3.6	0.6	0.2	0.0	0.0	0.0	3.9	4.2	0.0	0.0	0.0	5.4	0.0	0.8	3.2	4.7	0.1	0.5	0.0	0.0	0.3
GAD2	GAD65	ENSG00000136750	"Glutamate decarboxylase 2"	Q05329	10	26216307-26304558	"Enzymes, Predicted intracellular proteins"	"Neurotransmitter biosynthesis"	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 66.2"	"Cell type enriched"	"Detected in some"	11	"Pancreatic endocrine cells: 35.1"	"Group enriched"	"Detected in some"	21	"glioma: 0.7;pancreatic cancer: 3.0;testis cancer: 1.2"	"Region enhanced"	"Detected in all"		"basal ganglia: 66.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"MOLT-4: 5.2;SCLC-21H: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044637, CAB078177"	Enhanced					NA	NA					"CAB078177: AB_2665779, HPA044637: AB_10794053"		"unprognostic (8.67e-2)"			"unprognostic (1.11e-1)"						"unprognostic (4.93e-2)"		"unprognostic (2.52e-5)"	"unprognostic (5.44e-2)"	"unprognostic (8.08e-2)"			1.0	0.9	6.3	0.9	66.2	1.0	0.9	5.6	28.7	0.9	0.9	1.4	0.0	1.2	0.9	1.1	0.9	0.9	0.9	0.9	5.2	13.2	1.0	0.9	0.9	0.9	5.4	10.0	0.9	12.9	0.9	0.4	0.9	6.8	1.2	1.0	0.0	0.9	0.9	0.9	1.3	1.1	0.9	1.3	0.9	1.2	1.7	8.1	0.0	0.9	0.0	0.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	6.3	66.2	5.6	18.2	5.2	13.2	5.4	10.0	6.8	8.1	0.0	0.0	0.0	0.0	0.0	2.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	3.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	35.1	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0
GGACT	A2LD1	ENSG00000134864	"Gamma-glutamylamine cyclotransferase"	Q9BVM4	13	100530164-100589528	"Enzymes, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 47.0"	"Cell type enhanced"	"Detected in many"	10	"Proximal tubular cells: 65.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	5	"SCLC-21H: 55.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065320	Enhanced					NA	NA		75000			"HPA065320: AB_2685466"	"unprognostic (1.93e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.30e-3)"	"unprognostic (9.12e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.07e-2)"	"unprognostic (7.41e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.37e-2)"	"unprognostic (2.57e-1)"	3.6	6.6	3.2	3.4	3.4	0.9	3.4	2.6	4.5	2.0	4.9	3.6	1.7	5.7	4.0	3.4	2.8	2.5	5.5	1.7	2.6	2.2	47.0	10.9	2.4	4.6	3.5	2.1	2.5	9.8	1.8	1.9	2.1	4.4	2.4	3.4	4.1	12.0	14.2	2.7	3.1	6.7	3.4	4.3	6.1	4.4	11.0	3.3	3.7	2.5	5.0	6.4	2.5	2.5	5.2	4.2	1.0	7.5	8.0	8.3	4.2	5.6	0.7	4.6	5.0	3.9	6.1	2.0	3.5	0.9	0.6	1.6	0.0	5.1	0.5	2.0	2.5	0.1	0.3	0.7	1.0	0.2	7.9	3.1	2.3	0.5	0.3	5.6	3.3	7.8	7.2	4.0	0.1	0.3	0.0	2.3	2.6	1.2	0.1	0.9	0.3	0.5	0.4	0.2	10.8	1.5	0.3	1.1	0.6	5.7	0.9	55.0	2.1	1.1	2.5	2.5	4.5	2.4	11.2	2.2	0.0	0.0	1.2	0.9	3.0	1.6	0.2	0.3	2.5	2.5	0.0	5.1	1.0	7.9	7.2	7.3	5.2	6.4	8.3	4.2	5.0	4.0	5.9	0.0	8.0	7.5	3.0	6.5	4.2	3.2	3.4	2.6	4.5	2.6	2.2	3.5	2.1	4.4	3.3	0.0	1.0	10.4	3.4	2.4	1.1	0.8	0.0	0.0	2.3	7.0	13.7	9.8	6.6	8.4	4.1	3.1	5.3	0.0	9.0	10.2	2.8	2.2	5.7	13.2	10.5	1.6	7.5	4.3	7.8	6.7	2.6	3.6	0.0	8.2	4.5	4.8	8.0	2.9	3.5	65.3	2.1	6.5	0.9	18.2	10.5	1.8	3.7	5.0	7.1	1.6
GGCT	"C7orf24, CRF21, GCTG, Ggc, MGC3077"	ENSG00000006625	Gamma-glutamylcyclotransferase	O75223	7	30496621-30504844	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 343.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA020735, HPA029914"	Approved					NA	NA		2400000			"HPA020735: AB_1845754, HPA029914: AB_10602321"	"prognostic unfavorable (7.68e-4)"	"unprognostic (2.66e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.54e-3)"	"unprognostic (5.80e-2)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (1.33e-3)"	"unprognostic (2.19e-2)"	"unprognostic (6.42e-3)"	"unprognostic (2.66e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.12e-3)"	"unprognostic (2.00e-3)"	"unprognostic (9.92e-2)"	30.8	18.6	15.5	14.5	15.9	10.2	26.4	10.8	25.6	12.6	20.2	7.3	19.3	16.7	10.4	59.6	33.4	13.5	22.5	12.2	14.6	12.4	22.0	18.7	14.6	13.6	11.6	14.4	15.2	17.2	14.9	11.4	18.5	15.0	14.3	21.9	8.0	23.9	19.2	12.6	29.8	16.8	14.2	9.9	13.2	13.3	8.1	5.8	11.0	28.7	32.1	18.9	17.4	19.1	14.8	21.7	5.6	12.8	15.3	16.4	10.1	40.4	10.6	17.3	23.3	7.3	13.3	20.2	13.8	5.4	13.3	16.2	14.1	14.2	26.2	9.2	5.2	15.1	51.6	18.2	14.5	17.5	5.0	20.1	18.5	21.5	18.5	9.6	31.0	14.3	12.9	11.7	13.9	18.0	4.6	13.4	12.6	26.2	15.1	10.5	22.4	18.7	42.0	25.1	41.6	17.2	18.9	20.1	26.0	12.8	37.0	22.0	22.2	12.4	77.7	14.8	23.5	49.8	29.5	8.0	8.8	16.5	16.6	27.0	11.1	26.2	20.2	6.8	42.2	16.3	5.6	12.8	4.2	9.6	12.5	13.3	14.8	12.7	12.3	21.7	11.7	12.3	11.9	0.7	15.3	7.3	19.1	16.4	10.1	15.5	15.9	10.8	25.6	14.6	12.4	11.6	14.4	15.0	5.8	14.9	29.6	26.1	44.9	68.5	23.0	43.7	20.4	81.7	51.2	41.8	3.9	343.3	104.5	74.5	21.3	42.7	45.1	0.0	69.7	113.6	40.1	51.8	26.5	45.3	113.3	31.8	27.2	28.8	40.5	6.6	23.0	53.5	59.1	21.6	78.5	20.5	50.0	49.1	36.7	159.0	11.6	25.8	43.2	13.5	16.0	65.4	113.4	30.2	117.6	52.0
GLS	"GLS1, KIAA0838"	ENSG00000115419	Glutaminase	O94925	2	190880827-190965552	"Enzymes, Predicted intracellular proteins"		Hydrolase	"Cataract, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 127.9"	"Cell type enhanced"	"Detected in all"	6	"Collecting duct cells: 371.6;Proximal tubular cells: 372.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 141.8;RPTEC TERT1: 65.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036223	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	No	No		25000	Mitochondria		"HPA036223: AB_10669984"	"unprognostic (7.45e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (3.45e-4)"	"unprognostic (1.17e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.51e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.40e-1)"	"unprognostic (8.01e-2)"	"unprognostic (9.06e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.03e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.12e-1)"	16.5	37.3	37.8	20.4	24.7	10.7	34.3	43.8	47.3	11.9	13.1	5.8	8.9	36.9	14.6	11.9	7.6	11.0	17.7	15.7	23.3	22.8	127.9	5.3	22.6	25.4	20.6	36.8	14.1	17.0	26.4	10.1	14.8	35.1	9.4	13.1	10.8	9.0	13.9	7.4	13.0	40.9	15.5	11.7	19.3	8.7	6.9	12.1	15.0	17.7	8.0	22.9	14.1	16.1	5.2	5.0	6.0	2.1	3.9	9.4	1.5	6.4	7.1	5.0	6.6	15.7	11.0	13.0	19.2	14.6	14.0	16.1	8.7	6.4	13.2	141.8	40.5	7.1	8.4	8.8	7.5	20.6	32.5	5.7	21.9	10.5	10.7	14.4	12.7	10.3	9.9	7.9	11.0	7.5	14.0	18.1	5.5	10.1	26.9	31.1	3.4	8.6	12.3	13.4	3.8	11.7	11.0	12.9	11.4	65.2	11.8	6.9	7.2	26.2	5.8	24.4	18.7	2.3	7.9	12.9	20.3	14.9	10.1	23.2	8.7	19.8	18.1	7.3	10.5	16.1	6.0	1.5	2.5	5.5	2.1	9.4	4.8	6.5	7.0	2.2	5.2	6.8	8.1	3.0	3.9	1.4	5.0	5.6	1.5	37.8	24.7	43.8	47.3	23.3	22.8	20.6	36.8	35.1	12.1	175.7	95.7	52.1	47.3	155.0	91.0	32.2	30.6	16.0	40.9	371.6	198.3	3.3	43.1	22.6	4.4	51.8	120.5	23.3	20.9	10.2	63.7	42.0	35.8	4.9	25.8	25.4	56.7	57.7	27.2	3.6	26.4	55.5	84.4	88.4	25.7	10.0	29.5	31.6	40.7	372.1	117.6	19.4	70.9	10.7	11.0	142.3	3.3	62.3	28.1	52.1
GLS2	"GA, GLS, hLGA, LGA"	ENSG00000135423	"Glutaminase 2"	Q9UI32	12	56470944-56488414	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 92.2"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 52.1"	"Cancer enhanced"	"Detected in single"		"liver cancer: 1.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	29	"B-cells: 1.8;T-cells: 3.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 25.6;RPMI-8226: 4.6;SCLC-21H: 7.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038608	Uncertain					NA	NA					"HPA038608: AB_10673176"	"unprognostic (5.59e-2)"	"unprognostic (1.51e-2)"	"unprognostic (8.73e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.23e-2)"	"unprognostic (9.56e-2)"	"unprognostic (3.27e-3)"	"unprognostic (1.98e-6)"	"unprognostic (1.55e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.65e-5)"	"unprognostic (1.42e-2)"	"unprognostic (2.59e-1)"	"unprognostic (9.02e-2)"	"unprognostic (4.44e-2)"	0.9	1.7	5.7	1.0	8.6	0.9	1.4	12.8	15.0	1.0	1.2	0.2	0.0	1.0	1.2	2.0	1.4	2.8	0.9	1.0	4.2	4.1	1.6	92.2	1.4	1.2	1.9	9.7	1.2	15.8	3.0	6.2	0.8	8.6	1.4	1.7	2.5	1.4	2.0	0.9	2.0	1.0	1.1	3.2	1.1	1.4	1.1	1.4	0.0	1.4	0.0	1.4	1.1	0.8	1.8	0.0	0.0	0.0	0.0	3.8	1.4	4.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	3.5	0.9	25.6	0.5	0.0	0.0	0.6	0.0	3.8	0.0	0.0	3.8	0.0	0.3	4.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	1.8	0.8	0.4	0.0	0.1	4.6	2.7	1.8	7.3	0.4	0.8	0.3	0.0	0.7	3.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	3.3	1.8	3.3	1.0	0.0	0.6	3.8	3.5	0.0	0.0	0.0	0.0	0.6	1.4	5.7	8.6	12.8	15.0	4.2	4.1	1.9	9.7	8.6	1.4	0.0	2.4	1.9	4.2	1.4	9.5	0.0	0.0	2.7	6.8	0.0	5.9	0.1	6.6	0.4	0.0	0.3	0.0	0.0	1.6	0.0	0.1	1.5	1.1	52.1	0.1	3.2	1.2	1.3	1.5	0.0	0.9	0.0	1.7	0.0	0.0	2.3	0.8	0.0	0.0	0.5	10.2	0.0	0.0	0.0	1.0	1.0	0.2	0.0	0.2	0.3
GLUD1	"GDH, GLUD"	ENSG00000148672	"Glutamate dehydrogenase 1"	P00367	10	87050486-87094866	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 182.4"	"Cell type enhanced"	"Detected in all"	6	"Hepatocytes: 357.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 108.1"									"HPA042492, HPA044839, HPA061369"	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA		26000000	Mitochondria		"HPA042492: AB_2678024, HPA044839: AB_2679107, HPA061369: AB_2684494"	"unprognostic (1.48e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (3.81e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.57e-3)"	"prognostic unfavorable (1.76e-5)"	"unprognostic (1.13e-1)"	"prognostic favorable (1.44e-6)"	"unprognostic (2.29e-1)"	"unprognostic (4.23e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.27e-2)"	15.5	21.5	57.8	9.9	54.5	5.9	23.2	13.4	37.9	12.1	14.5	19.9	5.5	18.4	10.9	7.5	17.0	11.5	12.6	16.7	44.1	35.3	56.2	182.4	13.1	11.5	40.6	30.8	17.5	15.2	8.7	6.6	13.5	31.1	26.5	14.6	8.1	10.0	13.3	9.2	15.3	19.8	14.0	22.7	10.2	12.2	6.4	33.2	12.6	16.1	8.7	13.1	14.0	9.5	9.2	15.8	9.2	14.6	13.7	11.9	5.9	24.5	19.8	15.6	26.4	29.7	36.6	17.1	19.4	33.6	18.8	20.7	45.8	24.1	27.6	15.9	28.3	10.8	38.7	20.3	19.5	20.2	19.9	16.0	13.4	11.9	108.1	66.3	31.3	19.4	25.2	36.9	20.9	62.6	28.7	22.4	21.8	13.5	25.0	20.3	17.8	28.2	28.1	17.8	26.7	16.0	21.4	19.9	18.0	54.1	20.1	8.0	15.0	17.4	13.8	24.7	15.7	19.0	22.1	22.2	9.8	8.7	19.8	19.7	15.0	15.4	33.0	23.6	35.9	5.8	5.5	13.8	9.2	8.7	11.1	10.9	9.2	11.8	10.6	15.8	8.8	10.6	8.5	1.3	13.7	14.6	5.9	11.9	5.9	57.8	54.5	13.4	37.9	44.1	35.3	40.6	30.8	31.1	33.2	20.8	19.2	40.4	53.0	94.2	20.7	49.8	53.5	17.4	45.5	57.6	35.3	77.3	132.6	27.7	11.2	45.6	54.7	46.7	29.4	52.4	55.2	96.0	43.7	357.2	63.1	14.3	37.8	50.3	67.1	18.7	81.4	68.2	99.5	30.7	44.6	133.3	37.2	42.1	85.2	119.8	60.1	64.7	76.2	9.6	6.4	107.0	39.8	55.4	40.7	75.9
GLUD2	GLUDP1	ENSG00000182890	"Glutamate dehydrogenase 2"	P49448	X	121047588-121050080	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 11.3;testis: 31.9"	"Cell type enhanced"	"Detected in some"	6	"Cytotrophoblasts: 2.7;Hepatocytes: 3.2;Proximal tubular cells: 2.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HAP1: 8.0;K-562: 8.8;SK-MEL-30: 11.3;THP-1: 5.6;WM-115: 12.7"									"HPA042492, HPA044839, HPA061369"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA042492: AB_2678024, HPA044839: AB_2679107, HPA061369: AB_2684494"	"unprognostic (1.44e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.35e-1)"	"prognostic favorable (1.98e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.77e-3)"	"unprognostic (5.96e-2)"	3.1	2.5	4.8	0.8	7.3	0.5	1.6	2.2	3.5	1.1	0.7	2.0	0.6	0.6	1.0	5.2	0.7	1.0	1.6	1.5	5.7	1.8	4.7	11.3	0.9	0.9	2.7	6.2	0.7	1.5	0.7	0.7	2.7	4.3	0.8	0.6	0.2	0.9	3.1	0.7	0.8	1.0	1.0	1.5	0.5	0.9	31.9	4.1	0.0	1.4	0.0	0.8	0.8	0.6	0.8	1.2	0.7	1.1	1.2	0.7	0.4	0.0	2.1	0.5	0.0	0.0	0.0	0.1	0.6	0.6	0.1	0.3	0.0	1.1	0.0	0.8	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.9	2.2	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	1.7	0.0	0.0	1.6	4.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.4	11.3	0.3	2.7	5.6	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.7	0.6	0.8	0.7	0.4	1.1	0.7	0.8	0.7	0.7	1.2	0.4	0.7	0.5	0.0	1.2	1.1	0.2	0.7	0.4	4.8	7.3	2.2	3.5	5.7	1.8	2.7	6.2	4.3	4.1	0.0	0.0	0.0	0.4	0.0	0.0	2.0	0.0	0.0	0.0	0.0	2.0	2.7	1.7	0.1	1.8	0.0	0.0	0.0	0.3	0.3	0.6	0.3	0.0	3.2	0.5	0.0	0.0	0.0	1.9	1.5	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.9	1.1	0.1	2.1	0.0	0.0	0.1
GLUL	GLNS	ENSG00000135821	"Glutamate-ammonia ligase"	P15104	1	182381704-182392206	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Angiogenesis	"Ligase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Late spermatids: 6809.8;Muller glia cells: 5699.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 92.2"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 92.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 141.5;ASC TERT1: 100.1;HSkMC: 86.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007316, HPA007571, CAB008636"	Approved		Supported	"Plasma membrane,Mitochondria,Cytosol"		NA	NA		28000	"Mitochondria, Cytosol"	"Plasma membrane"	"CAB008636: AB_1616669, HPA007316: AB_888438, HPA007571: AB_1078980"	"prognostic favorable (4.81e-4)"	"unprognostic (1.52e-3)"	"unprognostic (3.89e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.52e-2)"	"unprognostic (7.58e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.55e-2)"	"unprognostic (4.53e-3)"	173.3	19.2	83.7	37.2	91.0	47.6	63.1	48.5	80.7	41.9	20.4	49.9	9.4	6.2	20.5	29.7	54.0	31.6	26.2	23.5	74.0	48.7	15.6	64.9	39.5	36.9	71.0	48.8	66.2	49.0	7.4	8.9	41.8	70.6	17.4	23.3	39.3	30.4	25.5	159.8	27.9	16.4	30.5	51.3	36.1	71.4	24.0	55.2	8.6	63.9	15.5	24.2	34.7	32.2	2.5	11.0	92.2	21.1	3.4	6.3	18.6	3.0	1.2	14.0	0.0	141.5	100.1	10.3	5.1	16.6	3.1	2.8	7.4	3.1	2.6	5.6	9.9	2.8	7.0	6.1	36.4	2.6	7.0	17.0	34.3	5.8	14.3	7.5	15.1	27.4	86.5	43.7	3.9	46.4	4.7	6.2	8.4	28.8	1.5	11.0	1.7	23.5	14.5	10.4	4.2	6.5	8.5	3.7	4.4	5.4	13.3	9.6	6.3	1.4	18.7	2.0	11.7	18.2	19.1	4.6	0.1	0.2	0.0	1.1	0.5	0.3	0.0	2.7	8.6	0.5	43.6	21.1	54.9	6.3	20.5	2.6	1.6	4.5	5.2	11.0	2.5	2.3	3.9	92.2	3.4	17.1	6.1	1.7	18.6	83.7	91.0	48.5	80.7	74.0	48.7	71.0	48.8	70.6	55.2	116.1	193.4	39.3	480.1	119.7	83.9	198.1	163.1	242.2	133.1	78.5	49.1	126.6	63.0	92.2	1437.2	175.0	45.7	210.2	99.7	54.7	230.2	354.1	758.5	179.4	734.4	41.3	312.5	129.5	692.2	6809.8	451.3	662.6	129.9	48.7	226.1	5699.1	116.5	83.4	352.5	40.4	128.3	90.5	209.3	38.8	52.4	112.0	196.8	96.9	130.8	1061.5
GOT1	AST1	ENSG00000120053	"Glutamic-oxaloacetic transaminase 1"	P17174	10	99396870-99430624	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis"	"Aminotransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 116.9;liver: 82.9;skeletal muscle: 102.1"	"Cell type enhanced"	"Detected in all"	9	"Cardiomyocytes: 398.1;Distal tubular cells: 203.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064532, HPA072629"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes		130000000	Nucleoplasm	Cytosol	"HPA064532: AB_2685279, HPA072629: AB_2686540"	"unprognostic (6.40e-2)"	"prognostic favorable (6.23e-4)"	"unprognostic (5.99e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.96e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.08e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.79e-1)"	"prognostic favorable (3.72e-13)"	"unprognostic (1.93e-2)"	"unprognostic (4.23e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.00e-1)"	3.3	14.0	15.7	3.6	32.1	2.0	5.9	22.9	56.4	13.5	12.0	9.7	5.9	14.7	3.4	7.0	10.3	4.6	12.2	116.9	19.4	19.0	34.6	82.9	3.5	3.4	17.8	16.4	3.8	8.2	15.9	4.9	3.7	49.9	5.9	14.7	9.0	12.4	7.2	102.1	4.5	12.7	5.4	7.7	3.6	10.1	9.3	4.7	3.3	11.7	31.3	7.1	4.9	4.0	10.6	21.4	3.9	16.8	11.4	15.6	8.8	17.2	9.6	11.3	28.6	8.7	7.5	32.0	14.2	26.1	24.7	27.1	21.7	14.1	16.9	4.9	11.9	21.0	21.7	25.8	18.7	27.4	5.8	11.0	6.4	12.3	28.2	46.5	18.3	11.0	11.9	20.2	21.0	57.1	16.8	12.0	11.2	16.5	26.5	15.8	15.6	9.8	13.8	7.2	27.0	13.4	10.7	10.8	17.6	43.2	9.5	4.9	7.2	10.7	15.2	52.9	17.4	29.0	6.3	5.5	6.3	14.1	6.8	16.2	18.9	22.3	17.3	16.6	9.6	8.4	2.4	5.3	3.9	12.4	14.7	11.4	10.6	13.5	12.9	12.9	10.2	10.2	14.5	0.5	11.4	16.8	21.4	15.6	8.8	15.7	32.1	22.9	56.4	19.4	19.0	17.8	16.4	49.9	4.7	14.9	14.4	29.9	39.5	10.5	86.5	398.1	96.8	26.8	14.8	69.8	58.9	29.8	203.9	43.4	86.1	13.5	75.3	46.7	27.1	14.9	9.9	11.6	32.2	145.9	26.2	71.5	18.9	17.2	11.6	9.5	10.3	9.5	47.2	14.4	30.8	29.4	25.5	30.3	13.4	123.7	55.6	12.9	14.1	28.9	11.5	9.2	46.1	12.1	50.2	36.7
GOT1L1	MGC33309	ENSG00000169154	"Glutamic-oxaloacetic transaminase 1 like 1"	Q8NHS2	8	37934281-37940129	"Predicted intracellular proteins"		"Aminotransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"testis: 16.4"	"Cell type enriched"	"Detected in some"	7	"Early spermatids: 100.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SuSa: 1.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA028778	Uncertain					NA	NA					"HPA028778: AB_10602138"														"unprognostic (6.93e-3)"	"unprognostic (5.46e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	100.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0
GOT2	"KAT4, KATIV, KYAT4, mitAAT"	ENSG00000125166	"Glutamic-oxaloacetic transaminase 2"	P00505	16	58707131-58734357	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Lipid transport, Transport"	"Aminotransferase, Transferase"	"Cancer-related genes, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 167.8"	"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 269.3;Hepatocytes: 145.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018139	Enhanced				"Intracellular and membrane"	NA	NA		7000000			"HPA018139: AB_1849903"	"unprognostic (1.50e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.73e-3)"	"unprognostic (2.63e-3)"	"unprognostic (3.02e-2)"	"prognostic unfavorable (1.61e-4)"	"prognostic favorable (5.75e-5)"	"unprognostic (1.12e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.00e-1)"	"prognostic favorable (2.90e-9)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.56e-2)"	"unprognostic (2.22e-1)"	6.1	21.0	12.7	8.0	19.1	5.5	10.7	19.4	35.7	10.6	15.9	16.0	33.3	10.6	10.4	19.5	17.7	13.5	8.9	78.1	15.8	16.7	24.6	85.5	7.1	11.1	16.2	17.8	8.7	8.8	27.0	13.0	7.3	27.7	17.2	18.8	23.4	13.0	20.5	167.8	10.4	9.4	13.5	12.3	8.0	13.6	10.8	9.9	10.7	12.3	53.9	15.0	15.5	11.2	14.3	17.6	3.5	9.9	14.5	24.5	14.3	27.6	37.6	19.8	24.1	14.4	13.0	26.0	21.3	22.7	42.0	23.1	32.5	25.0	61.9	25.3	23.5	18.4	40.9	42.4	41.3	53.6	17.0	38.9	16.6	20.5	36.3	18.3	26.7	15.4	12.6	23.5	26.4	23.1	24.0	42.1	30.0	33.4	6.4	21.3	24.7	33.2	25.8	26.9	18.5	73.0	36.5	30.2	59.4	39.6	40.7	31.7	23.0	40.7	43.9	15.3	18.7	22.1	8.7	16.9	15.3	28.0	11.9	27.0	14.9	13.8	50.7	16.3	26.8	15.4	2.3	9.9	3.5	15.2	8.6	23.5	14.3	18.0	18.4	17.6	10.6	16.7	15.3	0.9	14.5	8.5	15.5	24.5	14.3	12.7	19.1	19.4	35.7	15.8	16.7	16.2	17.8	27.7	9.9	8.9	12.0	18.2	27.1	28.4	31.7	269.3	33.1	13.4	14.8	34.9	72.6	40.0	48.0	48.1	3.5	16.6	29.5	23.3	36.8	30.5	15.1	29.5	13.9	145.0	34.4	19.1	19.8	25.8	17.4	5.6	16.7	14.4	23.6	9.0	29.0	15.2	34.5	5.8	21.2	51.6	42.1	0.0	14.7	11.2	14.7	26.2	19.8	14.4	49.8	58.8
GPT	"ALT1, GPT1"	ENSG00000167701	"Glutamic--pyruvic transaminase"	P24298	8	144502973-144507174	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminotransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 56.8;skeletal muscle: 27.0"	"Cell type enhanced"	"Detected in many"	14	"Enterocytes: 117.6;Erythroid cells: 70.0;Hepatocytes: 219.3;Proximal tubular cells: 85.9"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 38.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 2.3;non-classical monocyte: 2.9"	"Lineage enriched"	"Detected in single"	6	"monocytes: 2.9"	"Cell line enhanced"	"Detected in many"		"HaCaT: 4.4;Hep G2: 4.8;Karpas-707: 5.8;U-266/70: 6.1"	"Low region specificity"	"Detected in all"							"HPA031059, HPA031060, CAB032997, CAB032999"	Enhanced					NA	NA		15000000			"CAB032997: AB_2261949, CAB032999: AB_2095427, HPA031059: AB_10600214, HPA031060: AB_10602178"	"unprognostic (8.22e-3)"	"unprognostic (2.52e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.37e-2)"	"prognostic favorable (1.47e-5)"	"unprognostic (9.42e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.41e-1)"	"unprognostic (9.22e-2)"	"prognostic favorable (2.19e-4)"	"unprognostic (2.83e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.98e-2)"	9.0	0.8	1.7	8.7	2.2	1.1	3.9	1.5	2.3	0.2	17.4	2.0	4.6	10.9	0.2	1.7	0.9	0.5	19.8	16.9	1.7	0.9	8.7	56.8	0.2	0.2	1.3	2.2	0.4	3.6	0.5	1.1	0.1	2.0	0.7	3.5	1.6	17.0	2.7	27.0	6.1	19.2	0.2	0.7	0.4	8.6	0.8	1.6	0.0	0.6	13.9	3.3	0.3	0.5	0.0	0.5	0.0	2.9	0.0	0.0	0.0	0.5	1.5	0.4	1.2	0.9	0.0	1.3	0.8	0.0	0.0	0.0	0.5	1.9	0.8	0.7	0.0	0.1	4.4	0.0	0.0	0.0	1.5	2.8	0.7	2.6	4.8	0.0	0.1	0.8	0.0	0.4	0.0	0.0	0.7	0.0	1.0	0.5	5.8	0.0	2.6	0.9	0.9	0.7	1.1	1.0	0.9	0.3	3.1	0.0	1.9	1.2	1.8	0.5	1.5	0.2	0.3	3.9	0.3	0.4	0.4	1.3	1.3	0.2	6.1	0.4	0.4	0.8	1.9	0.4	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	1.7	2.2	1.5	2.3	1.7	0.9	1.3	2.2	2.0	1.6	0.0	0.0	14.9	1.1	1.4	1.0	6.5	20.4	0.0	0.0	7.0	0.0	0.0	18.3	1.0	17.0	0.0	117.6	70.0	2.1	2.2	0.2	1.1	9.2	219.3	0.1	3.2	2.4	11.6	8.2	39.1	0.6	0.0	1.7	0.0	32.3	13.8	1.4	42.1	0.4	85.9	2.0	0.0	0.1	0.7	0.4	4.0	0.0	3.8	23.4	1.1
GPT2	ALT2	ENSG00000166123	"Glutamic--pyruvic transaminase 2"	Q8TD30	16	46884378-46931297	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 103.0;skeletal muscle: 60.9"	"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 105.1;Muller glia cells: 57.6;Syncytiotrophoblasts: 69.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 4.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 49.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051514	Approved		Approved	Mitochondria		No	No			Mitochondria		"HPA051514: AB_2681516"	"unprognostic (1.65e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.95e-3)"	"unprognostic (3.44e-2)"	"unprognostic (6.12e-2)"	"prognostic favorable (3.17e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.86e-1)"	"unprognostic (3.54e-3)"	"unprognostic (3.18e-1)"	19.9	4.1	20.2	2.1	17.8	1.9	6.4	3.9	15.1	2.5	3.4	11.8	10.0	1.3	2.1	13.4	30.8	3.7	4.4	3.0	13.4	8.0	9.8	40.4	1.4	2.1	12.9	7.8	1.5	103.0	4.3	4.3	1.8	11.3	10.2	2.6	1.5	27.6	8.5	60.9	14.9	1.7	1.9	11.3	1.4	15.4	6.0	12.3	0.7	3.6	19.0	14.6	1.9	2.1	4.2	1.4	1.3	0.7	0.0	0.4	0.4	13.0	6.0	7.6	29.0	10.8	2.3	13.9	9.1	3.4	9.9	6.2	20.4	5.5	9.2	8.0	6.5	5.0	10.5	13.7	13.5	6.6	4.3	6.7	3.2	3.4	49.2	7.4	23.1	3.0	5.0	11.9	9.6	15.0	6.6	4.8	17.7	2.6	7.4	3.2	23.4	4.5	19.3	8.1	16.2	17.2	0.1	8.4	21.4	4.0	6.5	23.8	12.2	4.7	24.4	12.4	3.2	6.2	21.1	3.5	6.9	13.5	4.5	7.3	35.6	10.8	26.1	10.6	15.0	3.7	1.3	0.7	0.0	0.3	0.0	0.0	4.2	0.0	0.3	1.4	2.5	0.4	0.2	0.0	0.0	0.2	0.0	0.0	0.4	20.2	17.8	3.9	15.1	13.4	8.0	12.9	7.8	11.3	12.3	6.0	4.3	3.0	4.2	14.2	13.4	14.7	12.7	0.0	6.8	17.4	21.6	7.1	10.0	7.8	9.4	1.6	5.5	0.0	26.2	22.2	7.7	12.4	3.5	105.1	3.3	6.4	12.6	4.3	3.5	17.1	4.4	2.4	8.5	1.0	7.4	57.6	23.6	4.9	14.5	29.4	5.9	0.0	1.4	2.2	19.2	14.3	69.7	1.5	3.2	3.8
GSR		ENSG00000104687	"Glutathione-disulfide reductase"	P00390	8	30678061-30727999	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes, Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 61.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001538, CAB008632, HPA064806"	Approved		Supported	Cytosol		NA	NA		110000000	Cytosol		"CAB008632: AB_1616690, HPA001538: AB_1078986, HPA064806: "	"unprognostic (1.23e-1)"	"prognostic favorable (3.37e-4)"	"prognostic favorable (4.08e-5)"	"unprognostic (2.89e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.50e-1)"	"prognostic unfavorable (3.26e-5)"	"unprognostic (3.61e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.83e-2)"	"unprognostic (6.92e-3)"	"prognostic favorable (1.80e-4)"	"unprognostic (2.31e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.29e-1)"	8.9	14.4	6.8	10.7	9.1	7.9	6.2	9.1	11.8	18.6	18.7	7.1	18.4	20.4	13.2	12.0	19.4	8.8	17.3	11.9	5.0	5.7	27.9	17.8	10.8	9.7	4.9	6.0	11.8	17.6	22.9	7.2	8.9	6.8	16.4	17.2	10.9	12.0	17.4	14.7	6.5	31.8	9.3	4.5	13.6	17.7	7.9	4.2	17.0	9.2	11.8	12.0	23.9	14.5	2.5	4.7	19.0	5.7	2.6	7.3	2.1	11.6	49.4	8.0	6.2	8.6	9.7	7.7	5.2	11.5	7.4	10.0	14.5	6.2	22.8	25.8	6.7	22.0	13.1	12.1	11.3	8.2	5.9	11.2	23.0	17.1	48.5	23.2	7.0	37.0	16.1	7.1	11.1	4.5	8.1	10.5	14.5	19.0	10.1	16.7	10.6	24.7	8.2	14.2	48.3	8.8	9.4	9.2	11.0	14.8	29.6	6.1	7.8	7.2	16.8	12.5	11.2	7.2	8.0	14.3	3.1	8.6	7.3	7.7	5.6	6.2	14.7	9.9	9.9	10.1	19.0	4.6	11.5	4.2	4.2	7.3	2.5	3.8	4.6	4.7	2.0	2.4	3.1	6.5	2.6	5.7	2.9	3.2	2.1	6.8	9.1	9.1	11.8	5.0	5.7	4.9	6.0	6.8	4.2	3.0	21.0	15.2	10.5	3.8	6.1	21.4	30.6	9.4	14.8	12.2	15.7	11.8	8.3	9.6	6.9	8.0	61.3	0.0	17.1	5.3	5.4	23.6	5.8	37.6	15.4	3.2	32.7	15.4	38.4	14.1	6.6	12.8	8.5	5.4	52.8	11.8	14.3	34.0	10.3	14.4	7.5	6.5	6.2	1.2	4.4	4.6	5.4	11.3	38.8	23.0
KIAA0319	NMIG	ENSG00000137261	KIAA0319	Q5VV43	6	24544104-24646155	"Disease related genes, Predicted membrane proteins, Predicted secreted proteins"	Neurogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 23.5"	"Group enriched"	"Detected in some"	5	"Early spermatids: 57.8;Late spermatids: 47.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"memory B-cell: 1.4;neutrophil: 5.0"	"Group enriched"	"Detected in many"	32	"B-cells: 1.4;granulocytes: 5.0"	"Cell line enhanced"	"Detected in some"		"A549: 4.1;GAMG: 4.3;HDLM-2: 4.8;SCLC-21H: 7.8;U-266/84: 6.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015607, HPA076313"	Enhanced	Supported	Approved	Vesicles	"Secreted in brain"	NA	NA			Vesicles		"HPA015607: AB_1852299, HPA076313: AB_2732308"	"unprognostic (1.64e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.72e-2)"	"unprognostic (4.65e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.21e-5)"	"unprognostic (7.88e-4)"	"unprognostic (9.53e-4)"	"unprognostic (1.44e-6)"	"unprognostic (1.20e-1)"	"unprognostic (6.97e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.41e-2)"	0.9	1.9	9.9	1.3	10.2	0.9	1.1	10.7	23.5	0.9	1.6	4.0	0.0	0.9	0.9	0.9	0.8	4.8	1.4	0.8	9.7	7.7	0.9	0.8	2.2	0.9	5.8	12.1	0.8	3.0	0.8	3.8	1.1	10.2	1.7	1.7	0.0	0.8	0.9	0.8	2.4	1.1	1.1	1.4	1.1	3.2	3.5	2.3	0.0	0.8	0.0	1.1	0.9	0.1	1.4	0.0	5.0	0.0	0.0	0.0	0.0	3.6	4.1	0.2	2.6	0.0	0.0	0.1	0.0	0.1	0.1	0.3	0.2	1.5	1.1	2.0	0.0	4.3	1.7	0.7	0.0	0.0	4.8	1.8	0.0	3.5	0.2	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.3	0.0	1.9	0.0	0.2	0.0	1.2	0.1	0.0	0.5	0.2	0.3	0.2	0.0	0.8	0.1	0.2	7.8	0.5	0.1	2.2	0.0	0.1	0.8	0.0	0.0	0.0	0.6	0.4	0.8	0.6	6.3	0.3	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	9.9	10.2	10.7	14.9	9.7	7.7	5.8	12.1	10.2	2.3	3.0	0.3	0.0	0.0	0.0	1.8	1.2	0.0	10.7	2.3	0.0	0.0	0.0	0.0	0.2	57.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	9.8	0.0	0.0	47.2	0.6	0.0	0.0	1.0	0.7	0.2	0.5	0.0	0.7	0.0	1.1	0.0	0.0	0.9	1.4	0.0	0.6	0.0	0.3	0.2
KYAT1	"CCBL1, GTK, KATI"	ENSG00000171097	"Kynurenine aminotransferase 1"	Q16773	9	128832942-128882494	"Enzymes, Predicted intracellular proteins"		"Aminotransferase, Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	11	"Ciliated cells: 5.3;Cytotrophoblasts: 3.4;Distal tubular cells: 3.3;Proximal tubular cells: 6.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021176, HPA021177, HPA027736"	Approved		Supported	Cytosol		NA	NA		21000	Cytosol		"HPA021176: AB_1846120, HPA021177: AB_1846119, HPA027736: AB_10611818"	"unprognostic (6.51e-2)"	"unprognostic (8.67e-3)"	"unprognostic (1.05e-2)"	"unprognostic (5.98e-3)"	"unprognostic (2.15e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.47e-1)"	"unprognostic (8.60e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.65e-2)"	"unprognostic (3.10e-2)"	"unprognostic (5.79e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.98e-1)"	4.4	5.2	12.2	5.1	18.9	3.9	7.0	17.8	17.6	4.7	3.8	14.2	5.5	4.1	5.5	5.4	4.6	8.5	4.8	13.5	12.1	9.3	8.1	12.0	4.1	7.3	18.4	12.1	7.1	5.0	8.9	8.1	4.5	12.2	8.9	2.7	5.8	7.0	8.4	17.0	12.2	4.8	5.8	10.2	5.8	4.0	6.9	17.2	3.7	7.5	2.8	7.4	8.1	8.1	12.1	7.6	3.5	5.1	4.6	9.6	4.9	3.8	8.7	8.0	7.9	7.2	9.1	4.1	5.2	6.1	5.2	7.8	4.8	7.1	7.3	2.6	3.9	6.5	12.4	11.8	10.2	6.7	8.2	8.2	4.8	21.2	8.7	6.5	4.6	2.0	4.0	6.5	6.8	6.5	17.5	9.1	18.5	7.3	6.4	6.8	2.5	10.6	3.1	14.0	15.0	6.8	12.7	6.9	13.7	7.1	1.6	8.5	7.3	8.4	2.1	4.8	10.3	5.1	1.7	6.0	3.9	6.8	5.9	4.6	11.9	10.1	9.1	7.5	7.2	3.1	0.1	3.1	3.3	7.8	2.2	6.2	12.1	8.1	8.1	7.6	5.8	8.6	9.6	3.5	4.6	5.1	4.8	8.7	4.9	12.2	18.9	17.8	17.6	12.1	9.3	18.4	12.1	12.2	17.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	1.2	0.0	0.0	3.4	3.3	1.5	0.0	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0
KYAT3	"CCBL2, KAT3, KATIII, RBM1, RP11-82K18.3"	ENSG00000137944	"Kynurenine aminotransferase 3"	Q6YP21	1	88935773-88992953	"Enzymes, Predicted intracellular proteins"		"Aminotransferase, Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 59.0;monocytes: 55.9;Syncytiotrophoblasts: 69.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026538, HPA027168"	Enhanced		Approved	"Nucleoli,Cytokinetic bridge,Cytosol"		NA	NA			Cytosol	"Nucleoli, Cytokinetic bridge"	"HPA026538: AB_1852076, HPA027168: AB_1852078"	"prognostic favorable (3.19e-5)"	"unprognostic (3.36e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.01e-2)"	"prognostic favorable (1.86e-4)"	"unprognostic (2.61e-1)"	"unprognostic (3.61e-3)"	"unprognostic (2.11e-1)"	"prognostic favorable (2.80e-4)"	"unprognostic (1.04e-1)"	"unprognostic (3.17e-1)"	"prognostic favorable (5.02e-6)"	"unprognostic (1.17e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.78e-1)"	22.2	26.8	16.6	13.2	19.3	10.6	27.5	14.9	23.5	23.7	17.5	20.0	13.0	19.4	24.1	21.2	27.2	18.9	17.8	13.2	18.6	14.2	27.3	23.8	17.1	17.6	16.9	22.2	27.4	28.6	27.0	19.5	21.9	23.4	19.0	19.6	19.5	21.0	20.7	10.4	22.0	17.2	22.1	14.8	20.7	23.5	15.6	17.2	15.5	24.5	13.4	20.2	25.2	17.7	9.6	17.0	9.2	12.7	11.5	16.7	8.2	20.8	4.4	21.4	7.1	7.7	21.5	18.6	12.8	24.2	16.5	21.5	6.4	7.3	13.8	9.8	9.5	11.0	5.9	6.0	9.9	25.2	8.1	8.6	12.3	4.2	10.5	25.1	17.2	3.4	18.1	10.0	11.3	20.4	10.5	15.9	16.2	15.9	7.3	15.5	6.9	18.4	8.4	12.7	16.1	3.8	18.8	15.0	7.3	34.6	21.3	15.6	19.1	17.0	22.8	11.1	14.3	12.6	4.2	10.6	6.9	4.6	22.1	9.3	9.9	4.9	9.2	3.4	7.7	5.9	5.6	12.7	7.1	9.1	7.9	12.6	9.6	11.8	10.5	17.0	9.3	12.4	10.4	9.2	11.5	10.2	6.3	16.7	8.2	16.6	19.3	14.9	23.5	18.6	14.2	16.9	22.2	23.4	17.2	11.9	8.3	0.0	0.0	0.0	0.0	0.0	0.0	6.7	14.8	12.2	0.0	59.0	21.6	29.8	0.0	0.0	0.0	0.0	33.6	33.1	0.0	0.0	4.7	0.0	21.4	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	55.9	0.0	0.0	21.3	0.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	69.8	0.0	0.0	0.0
LDHA		ENSG00000134333	"Lactate dehydrogenase A"	P00338	11	18394388-18408425	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes, Disease mutation, FDA approved drug targets, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 249.1"	"Cell type enhanced"	"Detected in many"	4	"Basal keratinocytes: 1952.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB015336, CAB069404"	Uncertain		Supported	Vesicles,Cytosol		NA	NA		300000000	Cytosol	Vesicles	"CAB015336: AB_2134947, CAB069404: "	"unprognostic (8.83e-2)"	"prognostic unfavorable (2.78e-5)"	"unprognostic (3.81e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.43e-3)"	"unprognostic (4.66e-3)"	"prognostic unfavorable (3.26e-8)"	"prognostic unfavorable (2.27e-6)"	"unprognostic (1.08e-1)"	"unprognostic (1.88e-2)"	"prognostic unfavorable (8.09e-6)"	"unprognostic (1.76e-2)"	"prognostic unfavorable (9.69e-9)"	"unprognostic (4.15e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.05e-2)"	84.2	56.4	24.5	52.6	32.5	64.0	56.0	22.3	40.2	38.1	53.5	13.5	9.1	60.5	24.9	36.2	77.7	29.0	31.6	59.4	24.4	33.0	100.1	249.1	37.1	59.4	29.7	25.7	49.7	34.1	10.5	16.4	49.7	44.3	33.3	51.2	45.9	46.3	37.0	199.6	70.2	128.3	50.7	35.5	45.0	31.2	25.9	23.9	45.0	56.4	90.6	60.1	81.9	44.8	27.6	76.5	29.1	61.2	32.8	52.2	72.1	131.7	82.0	3.1	46.2	72.2	49.3	44.0	127.5	135.5	112.0	166.7	36.6	21.7	99.7	41.9	128.8	80.8	106.6	82.0	195.4	242.9	34.0	48.5	34.5	74.9	62.8	17.8	85.1	25.9	49.2	90.1	44.0	44.1	189.0	66.1	31.6	48.6	48.0	131.1	34.9	70.0	53.9	19.8	43.8	102.6	45.4	32.7	83.5	178.0	30.6	24.6	30.4	69.1	57.0	23.6	50.2	26.8	20.3	59.5	140.3	50.9	122.1	1.5	38.2	55.9	95.9	200.8	44.1	47.2	28.9	53.1	29.1	38.1	61.2	42.6	27.6	50.2	40.1	76.5	19.2	32.8	33.3	18.1	32.8	59.5	25.8	52.2	72.1	24.5	32.5	22.3	40.2	24.4	33.0	29.7	25.7	44.3	23.9	68.5	191.6	171.4	331.5	1952.6	415.5	222.7	142.7	85.6	187.7	293.1	137.4	475.1	368.1	1059.9	147.3	475.2	671.1	0.0	1350.8	1780.5	725.6	281.3	256.4	438.3	607.6	486.3	43.8	182.3	215.4	106.3	266.3	427.9	1116.8	1462.6	176.8	316.6	1380.9	487.5	192.7	408.8	354.8	187.5	1239.9	102.9	38.5	1506.3	419.6	213.6	251.8	384.9
LGSN	"GLULD1, LGS"	ENSG00000146166	"Lengsin, lens protein with glutamine synthetase domain"	Q5TDP6	6	63275951-63319977	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 5.2;liver: 9.3"	"Cell type enhanced"	"Detected in some"	9	"Ciliated cells: 4.0;Club cells: 3.4;Late spermatids: 2.2;Proximal tubular cells: 2.4"	"Cancer enhanced"	"Detected in some"		"lung cancer: 2.2"	"Region enriched"	"Detected in single"	7	"pons and medulla: 2.9"	"Cell type enhanced"	"Detected in some"		"neutrophil: 3.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 10.6;BEWO: 5.7;CACO-2: 3.4;HeLa: 3.9;Karpas-707: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030957, HPA039983"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA030957: AB_10670149, HPA039983: AB_2676784"	"unprognostic (1.94e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.03e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.05e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.53e-2)"	"unprognostic (4.51e-3)"	"unprognostic (1.64e-3)"	"unprognostic (1.31e-1)"		"unprognostic (2.19e-1)"	0.2	0.0	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	5.2	9.3	0.7	0.2	0.4	0.2	0.2	0.5	0.0	0.2	2.3	2.9	0.5	0.1	0.2	0.2	0.2	0.3	0.1	0.4	0.2	1.6	0.3	0.8	0.7	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.7	1.0	3.4	0.7	0.3	0.5	0.1	0.1	10.6	0.1	0.1	0.0	0.0	5.7	0.1	0.1	0.0	0.0	3.4	0.1	0.1	0.0	0.0	0.3	0.1	0.6	0.4	0.0	0.0	0.0	0.1	3.9	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	2.6	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.1	0.2	0.2	0.0	0.1	1.9	0.1	0.4	0.1	0.1	0.4	0.1	0.0	0.2	0.3	0.2	0.0	0.1	1.2	0.0	0.1	0.1	0.1	0.1	1.6	0.7	0.3	0.5	0.3	0.2	0.7	0.5	0.3	0.1	0.7	0.4	0.5	3.4	0.3	0.3	1.0	0.1	0.1	0.2	0.2	0.2	0.2	0.2	0.1	0.4	0.2	2.9	0.2	0.0	0.3	0.0	0.4	0.0	0.0	0.4	0.0	4.0	3.4	0.0	0.0	1.7	1.7	0.0	0.8	0.0	0.2	0.0	0.2	0.3	0.0	0.2	0.0	0.5	0.2	0.0	0.0	0.0	0.3	2.2	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.5	0.0
NAGS	"AGAS, ARGA, NAT7"	ENSG00000161653	"N-acetylglutamate synthase"	Q8N159	17	44004546-44009063	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Urea cycle"	"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 16.4;liver: 30.2"	"Cell type enhanced"	"Detected in many"	6	"Collecting duct cells: 12.2;Hepatocytes: 18.8;Proximal tubular cells: 14.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 6.4;HHSteC: 6.6;TIME: 8.1;U-87 MG: 12.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA027300			Supported	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA027300: AB_2672207"	"unprognostic (1.51e-3)"	"unprognostic (9.24e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.19e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.27e-1)"	0.6	0.6	0.5	0.4	2.4	0.0	1.0	0.7	1.5	0.3	7.2	0.5	5.6	16.4	0.5	2.6	0.9	0.3	0.3	0.9	0.7	1.5	4.4	30.2	2.5	0.2	1.8	0.6	0.5	0.3	3.6	0.4	0.4	1.2	0.8	0.4	0.1	0.9	6.5	0.1	0.6	13.4	0.3	2.0	0.5	0.3	0.4	1.1	0.2	2.9	0.0	0.1	0.8	0.8	1.5	2.0	2.3	2.7	1.0	3.5	1.3	3.4	0.2	0.0	0.5	0.0	6.4	0.1	0.6	0.0	0.2	0.0	2.2	0.8	0.0	1.4	0.0	0.1	1.5	0.0	1.2	0.1	0.3	0.8	0.1	0.2	2.7	6.6	0.0	0.0	2.8	0.1	0.2	0.0	0.6	1.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.4	1.7	2.7	0.1	0.2	0.0	0.0	0.0	2.6	0.0	1.2	0.0	0.0	0.1	0.2	0.1	8.1	3.0	0.8	0.2	0.7	0.2	0.2	0.2	12.1	0.1	0.4	1.8	1.4	2.3	3.5	1.5	2.8	1.2	2.2	2.9	2.0	1.5	1.1	1.7	0.8	1.0	2.7	0.3	1.7	1.3	0.5	2.4	0.7	1.5	0.7	1.5	1.8	0.6	1.2	1.1	3.0	3.4	0.5	0.8	1.3	0.4	2.4	5.1	1.4	4.5	12.2	0.0	0.9	6.6	1.6	4.4	0.9	10.4	0.0	3.6	1.6	0.6	0.4	0.0	18.8	1.0	0.0	6.9	1.3	2.6	2.2	1.4	4.2	0.0	9.0	2.6	0.9	3.7	3.2	0.7	14.6	0.5	0.0	1.0	5.5	1.5	0.6	0.3	1.5	3.3	0.6
NAT8L	"FLJ37478, Hcml3"	ENSG00000185818	"N-acetyltransferase 8 like"	Q8N9F0	4	2059512-2069089	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 45.9;brain: 45.9;testis: 11.8"	"Group enriched"	"Detected in some"	5	"Horizontal cells: 76.3;Muller glia cells: 25.6"	"Group enriched"	"Detected in many"	6	"endometrial cancer: 6.2;glioma: 17.2;melanoma: 14.6;ovarian cancer: 8.0;thyroid cancer: 7.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	28	"plasmacytoid DC: 3.8"	"Lineage enriched"	"Detected in single"	28	"dendritic cells: 3.8"	"Cell line enhanced"	"Detected in many"		"NB-4: 14.7;SCLC-21H: 19.0;SK-MEL-30: 15.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040677			Approved	Mitochondria		NA	NA			Mitochondria		"HPA040677: AB_2732486"	"unprognostic (1.32e-2)"	"unprognostic (8.62e-2)"	"unprognostic (3.02e-3)"	"prognostic unfavorable (1.01e-5)"	"unprognostic (2.56e-1)"	"unprognostic (2.63e-4)"	"unprognostic (6.58e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.54e-1)"	"unprognostic (3.70e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.78e-3)"	"unprognostic (7.24e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.35e-2)"	45.9	2.0	23.5	1.3	28.3	1.2	7.9	16.4	45.9	1.2	1.5	7.4	0.3	1.3	1.6	2.8	1.3	2.4	1.3	2.1	20.8	12.9	8.2	1.2	1.2	1.4	16.4	12.6	1.4	3.9	1.2	5.6	1.3	12.8	2.4	1.3	1.2	3.8	3.2	7.3	2.4	1.5	1.4	6.5	1.5	1.6	11.8	8.2	0.0	1.6	0.0	1.2	1.2	0.1	0.0	3.8	0.1	0.0	0.0	0.0	0.0	0.0	6.6	3.6	7.3	0.7	0.0	4.2	0.1	0.0	0.2	0.0	2.9	0.2	0.0	1.3	0.0	1.1	0.1	8.2	0.0	0.1	0.0	9.6	0.1	1.4	4.7	1.2	10.1	5.0	0.0	0.1	0.0	0.0	1.4	0.0	2.5	7.8	0.0	0.3	4.4	0.1	14.7	10.3	0.0	3.0	0.5	1.7	0.2	0.1	0.3	19.0	6.3	4.8	0.0	15.1	0.6	0.5	5.9	0.0	0.0	2.5	0.1	3.9	0.0	0.0	0.1	0.0	4.3	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	23.5	28.3	16.4	32.7	20.8	12.9	16.4	12.6	12.8	8.2	0.0	0.0	0.0	0.0	0.2	7.1	2.0	0.0	0.0	0.0	1.8	5.9	0.0	0.0	4.2	0.8	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.7	76.3	1.7	0.0	0.0	3.1	0.0	0.1	10.1	0.0	0.0	25.6	0.5	0.0	0.0	0.0	4.7	0.0	0.0	0.5	0.6	0.1	0.0	0.0	0.0	0.0
NIT2		ENSG00000114021	"Nitrilase family member 2"	Q9NQR4	3	100334701-100361635	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 41.1"	"Cell type enhanced"	"Detected in many"	10	"Proximal tubular cells: 436.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036999, HPA041289"	Approved		Supported	Centrosome,Cytosol		NA	NA		960000	Cytosol	Centrosome	"HPA036999: AB_10672105, HPA041289: "	"unprognostic (3.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.06e-3)"	"prognostic unfavorable (4.62e-4)"	"unprognostic (6.28e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.60e-3)"	"unprognostic (2.21e-1)"	"unprognostic (6.68e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.47e-3)"	9.9	7.4	6.7	5.4	9.9	5.9	12.4	3.7	10.5	6.4	7.2	6.1	10.6	5.5	6.6	13.3	9.2	7.9	7.1	7.4	5.8	6.3	29.8	41.1	5.6	8.9	5.9	8.0	7.2	8.5	4.7	7.6	4.9	7.7	7.2	6.8	11.3	8.2	10.2	14.7	7.7	5.3	7.0	5.4	5.7	6.8	3.3	3.3	4.4	10.8	14.5	10.5	8.2	5.6	4.2	5.9	1.5	2.4	3.0	4.3	1.3	9.9	9.9	1.2	5.2	8.9	12.1	6.2	4.1	6.1	9.7	9.3	8.4	11.2	10.0	6.2	5.9	4.2	7.5	4.5	11.0	11.6	3.1	2.3	7.2	3.2	4.3	10.9	4.7	4.9	7.6	16.8	5.2	8.5	5.1	6.2	5.7	3.3	8.1	11.8	9.5	3.1	4.3	4.4	12.5	15.1	3.5	4.2	9.8	16.0	6.3	6.9	3.2	5.6	9.6	6.1	3.3	7.1	4.5	4.5	6.1	2.5	2.9	3.5	5.0	5.5	8.5	9.6	8.0	7.7	0.4	2.4	1.1	3.3	2.1	4.3	4.2	3.1	2.5	5.9	3.7	3.6	3.5	1.5	3.0	1.6	1.8	3.1	1.3	6.7	9.9	3.7	10.5	5.8	6.3	5.9	8.0	7.7	3.3	11.9	12.1	26.5	41.3	29.0	11.3	49.4	30.6	38.8	26.1	55.8	15.7	80.0	159.2	63.8	2.3	15.5	14.9	0.0	46.2	64.1	34.7	40.0	20.7	147.3	56.1	12.7	23.1	16.0	18.8	2.4	40.9	33.3	47.2	136.1	20.8	11.7	55.0	25.7	35.3	436.2	23.6	38.8	46.4	1.5	14.5	36.4	49.5	26.2	34.7	40.6
PLPBP	PROSC	ENSG00000147471	"Pyridoxal phosphate binding protein"	O94903	8	37762593-37779767	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Distal tubular cells: 86.2;Exocrine glandular cells: 43.8;Hofbauer cells: 41.9;Proximal tubular cells: 63.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB017033, HPA023646, HPA023733"	Approved		Enhanced	Cytosol		NA	NA		20000	Cytosol		"CAB017033: , HPA023646: AB_1855741, HPA023733: AB_1855742"	"unprognostic (1.55e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.36e-1)"	"unprognostic (7.78e-3)"	"unprognostic (1.80e-1)"	"unprognostic (4.28e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.59e-2)"	"unprognostic (9.41e-3)"	"unprognostic (3.16e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.90e-1)"	"unprognostic (7.85e-2)"	23.3	18.2	22.0	14.6	23.3	8.4	20.6	19.7	23.2	15.7	29.1	16.1	18.3	21.3	17.2	16.2	14.0	18.9	16.4	30.1	19.7	21.4	37.0	48.2	16.5	14.7	20.7	20.3	17.8	38.4	26.2	17.9	13.2	15.3	19.5	25.5	15.2	18.6	19.2	32.6	11.0	24.7	19.4	18.5	15.1	20.0	7.2	15.4	16.6	30.6	15.7	18.3	20.1	28.8	27.4	40.0	46.1	46.5	24.1	39.2	34.2	17.4	17.1	14.2	12.8	10.7	13.1	11.1	20.0	18.1	13.9	15.8	20.3	9.1	21.0	23.9	15.9	22.4	16.0	26.4	21.0	23.3	17.4	11.1	29.1	6.8	19.4	21.1	13.2	19.8	9.6	19.6	13.4	21.8	15.5	20.9	30.1	15.3	16.8	11.6	12.9	42.6	12.3	16.8	36.1	14.0	28.0	17.4	12.3	22.7	22.9	8.4	9.2	16.5	8.0	20.8	10.9	17.4	17.4	18.5	7.7	23.5	25.8	13.0	16.5	32.4	15.6	10.8	19.4	13.7	46.1	38.4	45.6	31.8	43.8	33.3	27.4	32.6	30.5	40.0	22.9	29.2	27.8	16.2	24.1	46.5	23.7	39.2	34.2	22.0	23.3	19.7	23.2	19.7	21.4	20.7	20.3	15.3	15.4	8.9	24.5	0.0	0.0	0.0	0.0	0.0	0.0	25.4	14.8	29.6	0.0	17.4	86.2	32.4	0.0	0.0	0.0	0.0	43.8	26.8	0.0	0.0	11.6	0.0	41.9	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	20.8	0.0	0.0	30.6	0.0	0.0	63.4	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0
TAT		ENSG00000198650	"Tyrosine aminotransferase"	P17735	16	71565660-71577130	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Aminotransferase, Transferase"	"Disease mutation, Mental retardation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	44	"liver: 387.0"	"Cell type enriched"	"Detected in some"	42	"Hepatocytes: 3069.2"	"Cancer enriched"	"Detected in some"	10	"liver cancer: 152.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"Daudi: 2.4;Hep G2: 7.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (3.66e-3)"	"unprognostic (1.29e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.01e-2)"	"prognostic favorable (6.51e-4)"	"unprognostic (1.69e-1)"	"unprognostic (9.32e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.73e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.27e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.05e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	387.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.9	2.6	1.5	0.4	0.2	0.5	0.2	0.1	0.2	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.4	0.5	0.2	7.3	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.9	0.0	0.2	0.4	0.0	0.1	0.0	0.7	0.9	0.0	0.1	0.3	0.1	0.6	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.5	0.2	0.5	0.0	0.3	0.2	1.5	0.4	0.2	0.3	0.1	0.4	1.2	0.5	0.4	0.2	1.9	0.5	0.5	1.5	0.2	0.1	2.6	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.0	0.0	0.0	0.2	0.3	73.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	1.0	23.3	0.6	0.0	0.0	0.0	0.0	3069.2	0.0	0.0	0.0	53.4	61.8	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.9	1.5	0.0	0.0	0.0	0.0	0.0
